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In bacterial systems, small RNA (sRNA)-dependent translational repression is 
commonly carried out via sRNA-mRNA base pairing interactions near the Shine-
Dalgarno (SD) region. In this so-called “canonical” mechanism, the sRNA is the direct 
regulator; it competes with the initiating ribosomes while the chaperone protein Hfq plays 
a supporting role. Contrary to this widely accepted model, there are a few examples in 
the literature where the sRNA base pairs far from the SD region, yet translation of the 
target mRNA is still inhibited. Mechanistically, non-canonical translation regulation is one 
of the least understood aspects of sRNA biology. In the targetome of an E. coli sRNA 
SgrS, manXYZ is a non-canonical target where SgrS base pairs at two distinct sites that 
are far from the SD regions of manX and manY, yet translation of these two cistrons are 
repressed by SgrS. We found that manX translation is controlled by a molecular role-
reversal mechanism where an Hfq binding site is directly adjacent to the manX ribosome 
binding site. In this regulatory mechanism, SgrS plays the role of a guide to recruit Hfq to 
the appropriate binding site to form the silencing complex. We  also report that SgrS 
forms a duplex with a uridine-rich translation-enhancing element in the manY 5' 
untranslated region. Notably, we show that the enhancer is ribosome-dependent and 
that the small ribosomal subunit protein S1 interacts with the enhancer to promote 
translation of manY. In collaboration with the chaperone protein Hfq, SgrS interferes with 
the interaction between the translation enhancer and the r-protein S1 to repress 
translation of manY mRNA. Since bacterial translation is often initiated from a nonlinear 


































“I don't view myself as a practitioner of a particular skill or method. I'm constantly looking 
at what's the most interesting problem that I could possibly work on. I really try to figure 
out what sort of scientist I need to be in order to solve the problem I'm interested in 
solving.” 
-Erez Lieberman Aiden 
  
Aside from my mentors, most of my heroes are not some renowned professors. 
They are my friends, my partner, and my lab mates. Extraordinary humans disguised as 
ordinary people. They inspired me the most.  
My PI and a group of professors influenced me in a meaningful way. Even 
though they were busy, they were always happy to have a science conversation with 
me. Some of them were not my committee members; they just cared. The next hundred 
pages or so is filled with some exciting biology, without the stories of the people that 
cared for me, inspired me. These few lines are my inadequate attempt to express their 
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1.1 A Historical Perspective 
1.1.1 The roots of microbiology 
 We know little about all the bacteria roaming in our planet. Because we have 
sampled, sequenced, and studied a tiny fraction of them, most of the bacteria are 
familiar to us from few bits of genomic information gathered from natural samples. To 
this day, after a century of extensive research, basic research on the bacterium 
Escherichia coli continues to generate unexpected biological phenomenon. 
Nevertheless, the knowledge we have gathered can be compiled into volumes after 
volumes, and it is sufficient to initiate any scientific method to get a view into the inner 
workings of life. 
As the twentieth century began, multiple disciplines of science: physics, 
biochemistry, genetics, and chemistry cross-pollinated to initiate a new discipline- 
molecular biology [56]. A significant highlight of this period was the research on bacterial 
growth physiology by Monod, the creation of the “Phage Group” by Delbrück and Luria, 
and a book “What is Life?” by Erwin Schrödinger [90, 95, 120]. As the century rolled 
along, the field of molecular biology exploded with unprecedented breakthroughs on 
genetic analysis. With the explosion of biochemical approaches, it was possible to take 
full advantage of model organisms like Escherichia coli that, with relative ease, could be 
manipulated to prepare enzymatically active cellular extract and isolate macromolecules 
so that they could be tagged with radioisotopes. Quasi overnight, every molecular 
biology lab became engaged into exploration of major biosynthetic pathways, 
understanding of the concept of the gene and the genetic code, and most importantly, 
the molecular mechanisms of gene regulation.  
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Today, we have a remarkably detailed pictures of metabolic pathways; we know 
how and where most of the macromolecules are made. The major players of gene 
regulation are already identified, and the list is impressive. Nonetheless, there are 
considerable limitations in our understanding of how these players communicate with 
each other in response to signals to maintain cellular homeostasis and adapt to a 
favorable or a harsh environment. Until we understand thoroughly the paradigm of gene 
regulation, we will be handicapped in discovering the design principles of life. 
 
1.1.2 Escherichia coli and the rise of modern microbiology 
 As a member of the gut microbiome, E. coli thrived within our ancestors for 
almost five millions of years, predating Homo sapiens [73, 167]. In 1885, a German 
pediatrician, Theodor Escherich, isolated a rod shaped bacteria from baby diapers that 
thrived in almost all foods [34]. In his manuscript, he described this bacterium as 
“slender, short rods” and named it Bacterium coli communis [34]. Few years later, when 
Theodor Escherich passed away, scientists renamed it Escherichia coli [167].  
 With a moderate sized genome (4.6 m bp) of ~4,300 genes, the Gram negative 
bacterium Escherichia coli K-12 is a member of the phylum Proteobacteria, a subgroup 
of the Enterobacteriaceae family [11]. A major portion of the genome (87%) encodes 
protein-coding genes, 0.8% consists of stable RNA genes, and 0.7% encodes repeat 
elements, leaving only a tenth of the genome for regulatory functions [11]. E. coli cells 
are rod shaped, about 2.5 µm long with a diameter of 0.8 µm [9]. It leads a luxurious life 
in the lower intestine of warm blooded animals and a member of the human microbiome 
[9].  
At a first glance, E. coli is an unglamorous gram-negative bacterium, it does not 
differentiate, sporulate, photosynthesize, grow in extreme environments, communicate 
through a QS (quorum sensing) system, or encode any CRISPR immunity (although the 
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first sequenced CRISPR array was from E. coli [55]); yet the study of this organism is 
intricately intertwined with the explosion of modern molecular biology.  In 1922, a strain 
of E. coli (K-12) was isolated from a diphtheria patient in California; since then, it had 
been preserved by the Stanford University as a student laboratory strain [139]. This 
strain became the rock star model system when Joshua Lederberg, as a graduate 
student in Edward Tatum’s lab, started to study what he called “the long-shot gamble in 
looking for bacterial sex.” [69, 139] In the following decades, K-12 will become the 
organism of choice; scientists all over the world will run hundreds and thousands of 
experiments on it to learn some of the basic aspects of cell biology, including replication 
[72], transcription [129], translation, and the genetic code [56, 96], resulting in its 
ubiquitous use in academia, pharmaceutical industry, genetic engineering, recombinant 
protein production, and experiments in microbial evolution [12].  
 
1.2 Gene Regulation in Bacteria 
1.2.1 Transcriptional and post-transcriptional regulation 
 In response to environmental variations, bacteria use a wide range of 
sophisticated mechanisms to tune expression of genes. Any step in the gene 
expression, starting at the initiation of transcription to post-translational regulation, can 
be modulated by cells. Often, changes in gene expression, which frequently propagate 
through the highly connected gene regulatory network, is essential to maintain cellular 
homeostasis, activate stress response pathways, and change flux through the metabolic 
pathways [4].  
 One way in which bacteria ensure a well-coordinated regulation of gene 
expression is transcriptional control. Due to a short half-life of RNA transcripts, a pause 
or inhibition in transcription leads to rapid cessation of protein synthesis [158]. Post-
transcriptional gene regulation is employed when cells modulate the half-life and 
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translation of the mRNA transcript. Since the discovery of the regulatory RNAs, there 
has been an increasing appreciation for the significance of post-transcriptional gene 
regulation [130, 142]. 
 
1.2.2 RNA-mediated regulation in bacteria 
 In January of 1955, Francis Crick shared an unpublished paper among the RNA 
Tie Club members titled “On Degenerate Templates and the Adaptor Hypothesis,” 
perhaps the most remarkable unpublished paper in the history of molecular biology [23, 
156]. For years, Crick has been thinking about the relationship between DNA, RNA, and 
protein. In his adapter hypothesis paper, Crick argued that RNA was an intermediate 
between DNA and protein and developed a scheme to explain their relationship (known 
as the central dogma of molecular biology) [23]. This widely known hypothesis turned 
out to be true, and during the early days of molecular biology, scientists assumed that 
the sole purpose of mRNA is to serve as a template for translation. Research over the 
last few decades has discovered numerous RNA regulators (a heterogeneous group of 
RNA molecules that include riboswitches, non-coding RNAs, and CRISPRs) and 






























Fig. 1.1: Timeline of the major discoveries in small RNA research. In 1981, RNA I was 
first discovered, it inhibits the replication of ColE1 plasmid [142]. This discovery was 
quickly followed by first detection of a Tn10 encoded sRNA and a chromosomally 
encoded RNA MicF [86, 125], predating eukaryotic miRNA discovery [70, 108]. Based 
on experimental and computational predictions, current estimates suggests that the E. 
coli genome encodes more than a hundred sRNA [154]. 
 
 Almost 37 years ago, the first regulatory non-coding RNA, RNA I, was discovered 
in bacteria [142]. Since then, in all three domains of life, a surprisingly diverse yet poorly 
characterized pool of regulatory RNAs has been discovered (Fig. 1.1). Bacterial sRNAs 
are small transcripts, most in the range of 50-250 nucleotides; they act by imperfect, 
non-contiguous base pairing with mRNA targets to control translation or mRNA stability. 
Examples of positive regulation by sRNAs are less numerous compared to negative 
regulation, but sRNAs have been shown to pair with the 5´ UTR of an mRNA to prevent 
formation of a translation-inhibitory secondary structure [67, 91] or to pair with 
ribonuclease recognition sequences, thus stabilizing the mRNA (Fig. 1.2) [40]. For 
negative regulation, sRNAs often, but not always, operate as translational repressors by 
directly pairing with sequences overlapping the SD, sequestering it from the incoming 






Fig. 1.2: Positive and negative post-transcriptional regulation by bacterial sRNA. For 
positive regulation, sRNAs base-pair with the 5ˊ-UTR making the SD-region easily 
accessible for the initiating ribosome. Negative regulation is achieved when the sRNA 
base pairs near the SD region and inhibits translation initiation by competing with the 
initiating 30S subunit. Often, sRNAs base pair with the target mRNA promoting 
subsequent degradation by RNase E and the degradosome complex. 
 
To perform any of these regulatory tasks, sRNAs frequently depend on the 
chaperone protein Hfq. Hfq was initially discovered as the host factor for the replication 
of bacteriophage Qβ, but over the last few decades, its pleiotropic role in cellular 
physiology has reignited the interest of the research community [39]. Hfq has emerged 
as a key factor in sRNA-mediated gene regulation, and in control of stability of mRNAs 
and sRNAs [79, 88]. Hfq is thought of as a matchmaking chaperone that promotes 
interaction between the sRNA and the target by binding to both RNAs. Another key role 







1.2.4 Regulation of translation by bacterial sRNA 
Besides degradation, studies on sRNA mediated gene silencing have established 
translational repression as an important mode of gene expression regulation [17]. 
Studies over the last few years suggest that SgrS is capable of regulating multiple 
targets at the level of translation [76, 110]. The canonical model of translation initiation 
involves recognition of the SD by the incoming 30S ribosomal subunit, mediated by 
RNA-RNA interaction between the purine rich Shine-Dalgarno (SD) sequence and the 
16S rRNA of the 30S ribosomal subunit [124]. Generally, sRNAs target the translation 
initiation stage by occluding ribosome binding to a target mRNA. To inhibit initiation, 
however, the sRNA has to bind to a certain sequence window around the SD region (-20 





Fig. 1.3: The canonical mode of sRNA-mediated translation repression. In bacteria, 
translational repression by sRNAs involves sRNA-mRNA base pairing that occludes the 
SD region, directly preventing translation. In this mechanism, the sRNA is the direct 




Despite substantial progress in understanding the mechanism of translational 
repression, some crucial questions still remain to be answered concerning how the 
position of the base pairing site results in regulatory outcomes of translational regulation 
and/or mRNA degradation. There are several cases where an sRNA can base pair with 
regions of the mRNA away from the RBS, including the coding region, and still inhibit 
translation independent of mRNA degradation [17]. Sometimes, these non-canonical 
repression mechanisms can be achieved by the host factor Qβ (Hfq) by a ‘role-reversal’ 
mechanism. In such cases, Hfq assumes the primary role in translation inhibition in 
addition to its chaperone role. With the help of its partner sRNA, Hfq is recruited close to 
the SD region and prevents the 30S subunit loading [28].  
In addition to this ‘role-reversal’ mode of action, sRNAs can also bind to an 
upstream “ribosome standby site” and repress translation. This type of mechanism was 
first described for an antisense RNA IstR-1, which base pairs approximately 100 
nucleotides upstream of the ribosome binding site of tisB mRNA to represses translation 
[24]. The ribosome standby model was proposed by de Smit and van Duin as a mode of 
translation initiation that can be used when the SD region is occluded in a secondary 
structure [25]. The key assumption of this model is that the 30S subunit binds to an 
accessible single-stranded site, most likely “non-specifically”, near the secondary 
structure occluding the SD in order to wait for a brief opening of the secondary structure. 
A successful outcome of this interaction, the model proposes, is transient unfolding of 
the secondary structure, followed by relocation of the ribosome to the SD. If standby 
sites are occluded by an sRNA, translation will be inhibited.  
Translation initiation can also be modulated by other elements known as 
translation enhancers. These elements can be targeted by sRNA to repress translation. 
A recent study showed that Salmonella sRNA GcvB regulates various periplasmic 
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proteins using a conserved G/U-rich seed region that base pairs with target RNA 
sequences harboring C/A-rich repeat sequence [123]. When present, these C/A 
multimers stimulate translation in vivo and facilitate ribosome binding in vitro [123].  
These translation-stimulatory sites can be located upstream or downstream of the 
SD/start codon, a characteristic consistent with canonical translational enhancers. GcvB 
sequestration of the enhancer C/A-rich sequences therefore inhibits translation of target 
mRNAs. 
 
1.3 Protein Partners in sRNA Mediated Gene Regulation 
1.3.1 The chaperone proteins 
 A functional RNA molecule needs to maintain the correct conformation and avoid 
the tendencies to become kinetically trapped in inactive structures [115]. Over the last 
few decades, a diverse group of proteins has been discovered that help RNAs in 
reaching their correct conformation, facilitate interactions between two RNAs or, 
sometimes change the RNA secondary and tertiary structures by transient and non-
specific binding [48, 88, 104, 143].  
In bacteria, the ring-shaped homohexameric protein Hfq is perhaps the ‘poster child’ 
example of a RNA binding protein involved in sRNA-mediated gene regulation. Hfq was 
first identified as a host factor that unwinds phage Qβ RNA for efficient replication [57, 
58]. Since then, a volume of literature discovered its pleotropic role in endogenous gene 
control, ribosome biogenesis, and its role as a chaperone in sRNA mediated post-
transcriptional gene regulation [165]. Hfq is a member of the Sm/LSm protein family that 
binds and protects sRNAs from degradation, and in the current standard model, if the 
sRNA possesses adequate complementarity with a target mRNA, promotes formation of 
an active silencing complex [159]. The ternary complex (composed of sRNA, mRNA, 
and Hfq) typically sequesters the SD region, inhibiting translation of the mRNA [46, 80]. 
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 During the last decade, another chaperone protein ProQ has emerged as a new 
class of chaperone protein in Salmonella and E. coli [41, 45, 157]. Recent studies 
identified hundreds of transcripts that interact with ProQ and reinforced its role as a 
major regulator of bacterial motility, chemotaxis, and virulence genes [51, 157]. ProQ 
recognizes specific structural motifs of sRNAs and 3ˊend of mRNAs--it has both strand 
exchange and RNA matchmaking activity [41, 51]. Although the mechanistic aspects of 
the chaperone protein ProQ and the cellular roles of the ProQ associated sRNAs remain 
mostly unresolved, current understanding highlights the importance of the chaperone 
proteins in bacterial physiology, growth, and virulence.  
 
1.3.2 RNase E and the degradosome complex 
 A key player in sRNA mediated gene regulation is a single-strand specific 
endoribonuclease that is also involved in control and coordination of RNA metabolism 
including processing, maturation, and degradation of rRNA, tRNA, sRNA, and mRNA [1]. 
RNase E is an essential enzyme for E.coli that was first identified as a factor involved in 
processing of 9S rRNA precursor into mature 5S rRNA transcript [43]. The primary 
sequence of RNase E can be divided into two distinct regions: the amino terminal 
catalytic end, and the carboxy terminal RNA-binding region that harbors binding sites for 
RNA and other components of the degradosome [19]. RNase E is frequently recruited by 
the sRNA (and/or the chaperone protein Hfq), which subsequently forms into a 
degradosome, an sRNA-induced mRNA degradation complex [93]. The initial cleavage 
in the AU-rich RNA motif is catalyzed by RNase E followed by a rapid exonucleolytic 
degradation by PNPase, another member of the degradosome complex [18]. A typical 
degradosome also contains an ATP-dependent RNA helicase RhlB, and a prominent 




1.4 SgrS Rescues E. Coli During Sugar-Phosphate Stress 
SgrS is a 227 nt long Hfq-dependent small RNA that promotes both positive and 
negative effects on its targets [148]. It is involved in rescuing cells during a specific 
condition called glucose-phosphate stress. High amounts of sugar-phosphate 
accumulation inside bacterial cells cause toxicity through an unknown mechanism [153]. 
When cells are grown in presence of non-metabolizable sugar analogs, such as α-
methyl glucoside (αMG) or 2-deoxy-D-glucose (2DG), it creates a similar situation where 
phosphosugars are accumulated inside the cell, glycolysis is inhibited and the cells 
display a bacteriostatic phenotype [92, 146].  Like their metabolizable counterparts, 2DG 
and αMG enter the cell via the phosphoenolpyruvate phosphotransferase system (PTS). 
2DG and αMG enter the cell through the mannose transporter (ManXYZ, EIIABCDMan) 
and glucose transporter (PtsG, EIICBGlc), and get phosphorylated. Accumulation of 
sugars triggers an unknown stress signal that activates SgrR, a transcriptional activator 
of SgrS [148]. Work published by our group showed that these newly synthesized SgrS 
transcripts eventually base pair with the ptsG, and manXYZ transcripts and promotes 




Fig. 1.4: SgrS mediated regulation of manXYZ transcript. The PTS (PEP 
phosphotransferase) system uses a phosphorylation relay that transfers the phosphate 
from PEP to mannose transporter. When sugars are transported, they are 
phosphorylated. The accumulation of sugars inside the cell somehow activates SgrR, 
which activates the expression of SgrS. SgrS associates with the chaperone protein Hfq 
and base pairs with manXYZ. Base pairing stimulates RNase E-mediated degradation 
and translational repression. 
 
1.5 The Ribosomal Protein S1 and Its Role in Translation Initiation 
 The 5ˊ UTR region harbors two major determinants of translation initiation: i) 
Shine-Dalgarno (SD) sequence, a purine rich 3-10 nt long sequence located 
approximately 10 nt upstream of the start codon [124], and ii) A/U-rich sequence 
upstream of the SD sequence that are frequently exploited by the ribosome to enhance 
translation [14, 98, 137]. Several studies suggest that these translation enhancers 
stimulate translation via a direct interaction with the small ribosomal subunit protein S1 
[14, 31, 137].  
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S1 is not a typical ribosomal protein. It is unusually acidic, has high affinity for 
mRNA, and its association with the 30S ribosomal subunit is weak and reversible [30, 
60, 133]. Given its weak affinity for the ribosome (a binding constant of 2×108 M-1), 
existence of free S1 in ribosome free cell fractions, and the molar stoichiometry (<1 for 
every 30S subunit) in purified ribosomes, it is often argued that S1 should be considered 
as a translation factor rather than a component of the small subunit [27, 133]. S1 protein 
consists of six OB-fold repeats and it interacts with various heterogeneous RNAs, as 
well as poly U, poly A, and poly C homopolymers [30, 133]. The structure of this protein 
is yet to be resolved, but a recent cryo-EM study proposed an elongated shape shown in 
figure 1.5 [122]. 
 
 
Fig. 1.5: The 3D structure of the r-protein S1. It is composed of six structural motifs (OB-
folds, each approximately 70 amino acids in length) [122]. The domains are represented 
in different colors. Domains 1-3 at the N-terminal end interacts with the 30S ribosomal 
subunit (through r-protein S2) [31, 132]. 
 
A recent study on ‘minimal’ ribosomes found that ribosomes lacking the S1 
protein can efficiently translate leaderless mRNAs [87]. Apart from the leaderless 
mRNAs, the role of S1 can be crucial where the interaction between ribosome-
associated S1 and the 5ˊ UTR ensure rapid initiation complex formation [47, 140]. Often, 
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S1 interacts with polypyrimidine-rich sequence near the SD region and melts secondary 
structures and subsequently facilitates translation initiation complex formation [31]. 
 
1.6 Aim of This Study 
In this study, we investigated the mechanism by which SgrS regulates the first 
cistron of the manXYZ operon, manX. We observed previously that regulation of manX 
mRNA by SgrS involves base pairing 20 nucleotide downstream of the start codon, 
which lies outside the “five codon window” (a 15 nucleotide region, with respect to the 
start codon) [110]. We also characterized regulation of manX translation by another 
sRNA regulator, DicF [5], a 53-nt long Hfq-dependent sRNA [35]. The DicF binding site 
on manX mRNA is even further downstream than the SgrS binding site. We 
hypothesized that each of these sRNAs regulates manX translation by a “non-canonical” 
mechanism, since their binding sites are positioned too far downstream for sRNA-mRNA 
base pairing to directly occlude ribosome binding. To test this hypothesis, we addressed 
several questions. Does sRNA-mRNA duplex formation directly inhibit translation by 
preventing formation of the translation initiation complex? If not, then is Hfq required for 
translational repression?  Does Hfq bind to the manX mRNA near the ribosome binding 
site? 
SgrS base pairs with the manY 5ˊ UTR and the pairing region is 30 nucleotide 
upstream of the manY SD [109]. This is highly unusual since the base pairing site is 
positioned too far upstream for sRNA-mRNA base pairing to directly occlude ribosome 
binding and leads to the following obvious questions. Does sRNA-mRNA duplex 
formation directly inhibit translation by preventing the base pairing interaction between 
the 16S rRNA and the SD site? If not, then is Hfq required for translational repression?  
Does Hfq bind to the manX mRNA near the ribosome binding site? Also, does this base 




MATERIALS AND METHODS 
2.1 Strains and Plasmids 
 The strains, plasmids, and oligonucleotides used in this study are listed in Tables 
2.1 and 2.2. Derivatives of E. coli K-12 MG1655 were used for all experiments. Alleles 
were moved between strains using P1 transduction [83] or λ-red recombination [164]. 
Translational LacZ fusions, under the control of an arabinose-inducible PBAD promoter, 
were constructed by PCR amplifying DNA fragments using primers with into PM1205 
using λ-red homologous recombination (Table 2.2). These fragments were integrated 
into the chromosome by λ-red recombination using counterselection against sacB as 
described previously [77].  
 SA1328, a strain with tet-Cp19-115nt-manX`-`lacZ, ΔsgrS, lacIq, kanR, Δhfq 
genotype was constructed in two steps. First, Δhfq::FRT-kan-FRT was transduced into 
JH111 and pCP20 was used to flip out the kanR cassette. The tet-Cp19-115nt-manX`-
`lacZ cassette was then transduced into the latter strain. 
 Strains containing truncated manX translational fusions under the control of a 
PBAD promoter, were constructed in strain PM1205 [77]. The PBAD -22nt-manX'-'lacZ and 
PBAD -25nt-manX'-'lacZ fusions were generated by PCR amplifying DNA fragments with 
primer pairs O-SA178/O-SA176 and O-SA177/O-SA176 primer pairs respectively, 
containing 5´ homologies to pBAD and lacZ (Table 2.2). The PCR products were 
recombined into PM1205 using λ-red homologous recombination as described 
previously. The same fusions with mutations in the Hfq binding site (in strains SA1522 
and SA1620), were created using the method above, but using oligonucleotides O-
SA177/O-SA176 and O-SA177/O-SA433 to obtain the PCR products. 
The manY 5ˊ-UTRˊ-ˊlacZ and thrS 5ˊ-UTRˊ-ˊlacZ translational fusions with wild-
type 5ˊ-UTR and with mutations in the enhancer region was generated using single 
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stranded oligos (containing 5´ homologies to pBAD and 3ˊ homoogies to lacZ) into 
PM1205 using λ-red homologous recombination. The same protocol was used to 
generate a set of manY 5ˊ-UTRˊ-ˊlacZ strains with a combination of i) strong and weak 
SD regions, and ii) wild-type and mutated enhancer elements (Table 2.1 and 2.2). 
Plasmids encoding wild-type and mutated rpsA under the control of a weak and a 
strong SD sequences were constructed in a pWKS30 vector by PCR amplifying rpsA 
gene from pET28-rpsA (for WT S1) and pET28-mrpsA (for a mutated version of the S1 
protein) using OSA774/OSA776 (for strong SD) and OSA775/OSA776 (weak SD) primer 
pairs. Assembly of these PCR fragments with the pWKS30 backbone (amplified with the 
primer pair OSA783/OSA784) were performed using the NEBuilder® HiFi DNA 
Assembly Master Mix (following manufacturer’s instructions). 
 
2.2 Media and Reagents 
 Unless otherwise stated, bacteria were cultured in LB broth or on LB agar plates 
at 37°C. TB medium was used for β-Galactosidase assays. To induce Lac promoters, 
0.1 mM IPTG (isopropyl β-D-1-thiogalactopyranoside) was used.  L-arabinose was used 
at concentrations of 0.001%, for solid media, and 0.002%, for liquid media, to induce 
PBAD promoters.  Antibiotics were used at following concentrations: 100 µg/ml ampicillin, 
25 µg/ml chloramphenicol, 50 µg/ml spectinomycin, and 25 µg/ml kanamycin. 
 
2.3 β-Galactosidase Assays 
 Strains with manXˊ-ˊlacZ fusions were grown overnight in TB medium and 
subcultured 1:100 to a fresh medium containing Amp and 0.002% L-arabinose (for PBAD 
promoters). Cultures were grown at 37°C with shaking to OD600~0.2, and 0.1 mM IPTG 
was added to induce expression of SgrS or DicF. Cells were grown for another hour to 
OD600~0.5. β-Galactosidase assays were performed on these cells according to the 
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previously published protocol [82]. Unless mentioned otherwise, strains with manY 
UTRˊ-ˊlacZ fusions were grown overnight in TB medium and subcultured 1:100 to a 
fresh medium containing Amp and 0.002% L-arabinose. Cells were grown at 37°C with 
shaking to OD600~0.5 and β-Galactosidase assays were performed.  
For assays conducted on strains in Fig.  4.8, culture conditions were slightly 
different. Strains with manY'-'lacZ, thrS'-'lacZ, and sodB'-'lacZ fusions harboring WT S1 or 
mS1 plasmids were grown overnight in TB medium and subcultured 1:100 to a fresh 
medium containing Amp. Cultures were grown at 37°C with shaking to OD600 ~0.4, and 
0.002% L-arabinose (final concentration) was used to induce expression of reporter 
fusions. Cells were grown for another 20 minutes and 0.1 mM IPTG (final concentration) 
was added to induce S1 or mS1 production. Cells were grown for an additional 10 min 
before β-Galactosidase assays were performed. SgrS was induced by adding 0.5% αMG 
(final concentration) to the media. 
 
2.4 In Vitro Transcription  
 For in vitro transcription, template DNA was generated by PCR using gene 
specific oligonucleotides with a T7 promoter sequence at the 5´ end of the forward 
primer. The following oligonucleotides were used to generate templates for RNA 
footprinting and gel shift assays: O-JH219/O-JH119 and O-JH218/O-JH169 to generate 
manX and SgrS template DNA. DNA template for DicF transcription was generated by 
hybridizing two oligos, DicFW and DicFC, in TE buffer. Oligonucleotide pairs 
OSA753/OSA754 and OSA734/OSA735 were used to PCR amplify manY and thrS 
templates from MG1655 genomic DNA. Transcription of these DNA templates was 





2.5 Protein Purification 
2.5.1 Purification of Hfq 
Hfq-His protein was purified following a previously published protocol [76]. 
BL21(DE3) cells harboring pET21b-Hfq-His6 was cultured in 400 ml LB medium. At 
OD600~0.3, 1 mM IPTG was added to the culture and incubation was continued for 2 hrs. 
The cells were washed with STE buffer (100 mM NaCl; 10 mM Tris·HCl, pH 8.0; 1 mM 
EDTA) and resuspended in 10 ml Equilibration buffer (50 mM Na2HPO4–NaH2PO4, 300 
mM NaCl, and 10 mM imidazole). The suspension was treated with 25 mg lysozyme, 
incubated on ice for 10 min and sonicated. The supernatant was collected after 
centrifugation at 16,000 × g for 10 min at 4°C followed by incubation at 80°C for 10 min. 
The sample was centrifuged again, at 16,000 × g for 10 min at 4°C. The supernatant 
was fractionated using a Ni2+NTA agarose column following manufacturer’s instructions 
(Roche) and checked by SDS-PAGE electrophoresis. The fractions containing Hfq were 
pooled, dialyzed, and stored in a storage buffer (20 mM Tris·HCl pH 8.0, 0.1 M KCl; 5 
mM MgCl2, 50% glycerol, 0.1% Tween 20, and 1 mM DTT) at −20°C. 
 
2.5.2 Purification of S1 
 A DNA fragment containing the rpsA gene was PCR amplified from MG1655 
genomic DNA using OSA632/OSA633 primer pair. The pET28 backbone was PCR 
amplified with OSA636/OSA637 primer pair using pET28-Scy-C as a template (a gift 
from the Nair lab, University of Illinois at Urbana). The fragments were assembled into 
pET28-rpsA plasmid using the NEBuilder® HiFi DNA Assembly Master Mix (following 
manufacturer’s instructions). Primer pair OSA779/OSA780 was used to PCR amplify 
pET28-rpsA and introduce mutations into the rpsA coding region. The amplified PCR 
product was circularized using the NEBuilder® HiFi DNA Assembly Master Mix to 





Fig. 2.1: The pET28-rpsA expression vector encoding the His-tagged S1 gene under the 
control of a T7 promoter. The poly-histidine tags are preceded by a thrombin cleavage 
site. 
 
S1 was purified following a published protocol with modifications [134]. E. coli 
BL21 (DE3) cells with the pET28-rpsA vector was grown to late exponential phase. 
Around OD of 0.6-0.8, the expression of the protein was induced with IPTG (1 mM, final 
concentration) and the incubation was continued for 4hr at 370C. At this point, cells were 
harvested by centrifugation and the cell pellet was resuspended in 30 mL of extraction 
buffer (1X PBS, 0.5 M NaCl, pH 7.2) and lysed in a French press. The supernatant was 
collected after centrifugation at 16,000 × g for 10 min at 4°C. The supernatant was 
fractionated using a Hi-Trap Ni2+ column (GE Healthcare) following manufacturer’s 
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instructions (Roche) and checked by SDS-PAGE electrophoresis. The fractions 
containing S1 were dialyzed overnight in TGED buffer (10 mM Tris-HCl pH 8, 5% 
glycerol, 0.1 mM EDTA, and DTT 0.015 mg/mL) and loaded on a mono-Q column (GE 
Healthcare). The column was washed with TGED buffer and protein was eluted with a 
linear gradient of TGED buffer with NaCl (0.1 M-1 M). The fractions containing the S1 
protein were pooled, dialyzed, and concentrated using Centricon 10 concentrator 
(Millipore-Sigma). The poly-histidine tag was removed using the Thrombin cleavage kit 
(Millipore-Sigma) following manufacturer’s instructions. The cleaved proteins were 
further resolved in a Superdex 200 column with TGED buffer containing 0.1 M NaCl. The 
column fractions containing S1 were concentrated using Centricon 10 concentrator 
(Millipore-Sigma), mixed with an equal volume of 100% glycerol and stored at -200C. 
 
2.6 Toeprinting Assays 
 Toeprinting assays were performed using unlabeled manXATG and P32-end-
labeled primer in the presence and absence of Hfq and SgrS following the previously 
published protocol [36]. For each reaction, 2 pmol of manX RNA and 1.6 pmol of end-
labeled primer (O-JH119) were heated for one min at 95°C in toeprint buffer (20 mM 
Tris-HCl pH 7.5, 50 mM KCl, 0.1 mM EDTA, and 1 mM DTT). The mixture was chilled in 
ice for five minutes, and 10 mM MgCl2 and 1 mM of dNTPs were added. Purified Hfq and 
in vitro synthesized SgrS RNA were added to the appropriate reaction mixtures and 
incubated at 37°C for 10 minutes. Next, ribosomes (1.3 pmol, NEB) were added to this 
reaction mixture, and the incubation was continued at 37°C for five minutes. Thirteen 
picomoles of fMet-tRNA (Sigma) was added to this reaction and cDNAs were 
synthesized using SuperScript III reverse transcriptase (Invitrogen).  The reaction was 
stopped by adding 10 µl of loading buffer II (Ambion). The reaction products were 
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analyzed on an 8% polyacrylamide-urea gel. Sequencing ladders were generated using 
Sequenase 2.0 DNA sequencing kit (Affymetrix). 
 
2.7 Footprinting Assays 
2.7.1 Hfq and SgrS footprints 
 In vitro RNA-footprinting reactions were performed as described previously [29] 
with some modifications. 0.1 pmol of 5´-end labeled manX mRNA was incubated at 37°C 
for 30 minutes in structure buffer (Ambion) containing 1 ng of yeast RNA (Ambion), in 
the presence or absence of 100 pmoles of unlabeled SgrS and 3.7 pmoles of Hfq. Lead 
acetate (Sigma) was added to perform the cleavage reaction (2.5 µM) and incubated at 
37°C for two min. Reactions were stopped by adding 12 µL of loading buffer (Ambion). 
The alkaline ladder was generated by incubating 5´-end labeled manX mRNA at 90°C 
for 5 minutes in alkaline buffer (Ambion). RNase T1 was used for 5 min at 37°C to 
generate the G-ladder. The samples were resolved on an 8% polyacrylamide-urea gel. 
 
2.7.2 Ribosome footprints 
0.1 pmol of 5´-end labeled manY and thrS mRNAs were incubated at 37°C for 30 
minutes in structure buffer (Ambion) containing 1 ng of yeast RNA (Ambion), in the 
presence or absence of 10 pmol E. coli 70S ribosome (NEB). Lead acetate (Sigma) was 
added to perform the cleavage reaction (2.5 µM) and incubated at 37°C for two minutes. 
Reactions were stopped by adding 12 µL of loading buffer (Ambion). The alkaline ladder 
and the G-ladders were generated as described before. The footprinting samples were 






2.7.3 DEPC footprints 
 The DEPC footprint experiment was performed following a published protocol with 
some modifications [14]. In brief,  5 pmol of in vitro transcribed manY transcript was 
incubated with WT or mS1 protein (3 µM, final concentration) at 37 ºC for 10 minutes in 
binding buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl2, 100 mM NH4Cl, and 0.5 mM DTT). 
1 µL DEPC (Sigma, undiluted) was added to the reaction mixture and incubated at room 
temperature with gentle shaking. Reactions were stopped with 40 µL stop solution (0.4 M 
Na-acetate pH 5.2, and 20 mM EDTA). Modified manY transcripts were phenol extracted 
and precipitated with ethanol. Using a reverse primer (OSA754), primer extension was 
performed with α32P dATP (Perkin-Elmer) in the reaction mixture. Sanger ladders were 
generated using the Sequenase Version 2.0 DNA Sequencing Kit (Applied Biosystems). 
 
2.8 Electrophoretic Mobility Shift Assays 
 RNA-RNA and RNA-protein gel electrophoretic mobility shift assays were 
performed using 0.01 pmol of P32-labeled denatured manX RNA and the indicated 
amounts of SgrS (denatured at 95°C for 1 min) or Hfq in binding buffer (10 mM Tris-HCl 
pH 8.0, 0.5 mM DTT, 0.5 mM MgCl2, 10 mM KCl, 5mM Na2HPO4–NaH2PO4 pH 8.0). The 
mixture was incubated at 37°C for 30 min, and non-denaturing loading buffer (50% 
glycerol and 0.1% bromophenol blue) was added. The samples were resolved on a 4.6% 
native polyacrylamide gel for 1.5 h at 10 mA. The fraction of manX RNA bound was 
determined using Fluorescent Image Analyzer FLA-3000 (FUJIFILM) to quantitate the 
intensities of the bands. The data were fit into Sigmaplot software to obtain the KD value. 
 Hfq-sRNA-target mRNA gel mobility shift assays were performed using 0.01 
pmol of P32-labeled manY RNA and the indicated amounts of SgrS and Hfq in binding 
buffer. The mixture was incubated at 37°C for 30 min. Hfq was removed from the 
reaction with phenol extraction. A non-denaturing loading buffer (50% glycerol and 0.1% 
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bromophenol blue) was added to the aqueous phase and the samples were resolved on 
a 4.6% native polyacrylamide gel for 1.5 h at 10 mA. The fraction of manY RNA bound 
was determined using Fluorescent Image Analyzer FLA-3000 (FUJIFILM) to quantitate 
the intensities of the bands. The data were fit into GraphPad Prism7 software to obtain 
the KD value. 
 
2.9 In Vitro Translation 
 In vitro transcribed myc tagged manY transcripts (1 pmol, with and without 
translation enhancer) were translated in vitro using the PURExpress translation kit 
(NEB). Translation reactions were stopped by adding Laemmli sample buffer (Bio-Rad). 
The samples were resolved in a NuPAGE gradient gel (Life Technologies) and 
transferred to Immobilon-PSQ membrane (Millipore-Sigma). The membranes were 
incubated in a blocking buffer with anti-myc antibody (Sigma). The signals were 
visualized with ECL western blotting substrate (thermo Scientific). 
 
Table 2.1 Strains and plasmids used in this study 
 
Strain  Description  Source 
DJ480 ∆lac X74 D. Jin, NCI 




JH111 λattB::lacIq-PN25tetR-specR ΔsgrS [110] 
JH184 tet-Cp19-ptsG`-`lacZ, ΔsgrS, lacIq, kanR [110] 
SA1522 PBAD-25nt(mutated Hfq binding site)-manX’-‘lacZ, 
mal::lacIq 
This study 
JH175 tet-Cp19-115nt-manX`-`lacZ, ΔsgrS, lacIq, kanR [110] 
SA1328 tet-Cp19-115nt-manX`-`lacZ, ΔsgrS, lacIq, kanR, 
Δhfq 
This study 
JH178 tet-Cp19-65nt-manX`-`lacZ, ΔsgrS, lacIq, kanR [110] 
JH181 tet-Cp19-30nt-manX`-`lacZ, ΔsgrS, lacIq, kanR [110] 
SA1403 PBAD-22nt-manX'-'lacZ, mal::lacIq This study 




Table 2.1 (cont.) 
 
Strain  Description  Source 
DB151 ΔsgrS, λattB::lacIq, tetR(ep), spR, hfq::cat, ptsG'-
'lacZ 
[109] 
SA1620 PBAD25nt(mutated Hfq binding site)-manX19ˊ-
ˊlacZ, mal::lacIq 
 




SA1747 PBAD-manY UTR-ATG'-'lacZ, ΔaraBAD araC+, 
mal::lacIq 
This study 
SA1735 PBAD-mut1-ATG'-'lacZ, ΔaraBAD araC+, mal::lacI
q This study 
SA1736 PBAD-mut2-ATG'-'lacZ, ΔaraBAD araC+, mal::lacI
q This study 
SA1737 PBAD-mut3-ATG'-'lacZ, ΔaraBAD araC+, mal::lacI
q This study 
SA1738 PBAD-mut4-ATG'-'lacZ, ΔaraBAD araC+, mal::lacI
q This study 
SA1739 PBAD-mut5-ATG'-'lacZ, ΔaraBAD araC+, mal::lacI
q This study 
SA1748 PBAD-mut6-ATG'-'lacZ, ΔaraBAD araC+, mal::lacI
q This study 
SA1749 PBAD-mut7-ATG'-'lacZ, ΔaraBAD araC+, mal::lacI
q This study 
SA1801 PBAD-WT thrS UTR'-'lacZ, ΔaraBAD araC+, 
mal::lacIq 
This study 
SA1811 PBAD-G-thrS'-'lacZ, ΔaraBAD araC+, mal::lacI
q This study 
SA1815 PBAD-A-thrS'-'lacZ, ΔaraBAD araC+, mal::lacI
q This study 
SA1516 PBAD-manY UTR(Δenh)'-'ATG-lacZ, ΔaraBAD 
araC+, mal::lacIq 
This study 
SA1517 PBAD-manY UTR(Δenh)'-'ATG-enh(in frame)-lacZ, 
ΔaraBAD araC+, mal::lacIq 
This study 
SA1806 PBAD-flip-enh manY UTR'-'lacZ, ΔaraBAD araC+, 
mal::lacIq 
This study 
SA1807 PBAD-manY UTR with a strong SD and mut3 
enhancer'-'lacZ, ΔaraBAD araC+, mal::lacIq 
This study 
SA1808 PBAD-manY UTR with a lacZ SD and mut5'-'lacZ, 
ΔaraBAD araC+, mal::lacIq 
This study 
SA1809 PBAD-manY UTR with a weak SD'-'lacZ, ΔaraBAD 
araC+, mal::lacIq 
This study 
SA1810 PBAD-manY UTR with a strong SD'-'lacZ, 
ΔaraBAD araC+, mal::lacIq 
This study 
SA1916 PBAD-mut9 ATGˊ-'lacZ, ΔaraBAD araC+, mal::lacI
q This study 
SA1917 








PBAD-mut15 ATG'-'lacZ, ΔaraBAD araC+, 
mal::lacIq 
This study 
SA1907 PBAD-manY UTR-ATG'-'lacZ, hfq::kan, ΔaraBAD 
araC+, mal::lacIq 
This study 
SA1902 PBAD-sodB'-'lacZ, ΔaraBAD araC+, mal::lacI
q This study 
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Table 2.1 (cont.) 
 
Strain Description Source 
SA1755 
PBAD-manY UTR-ATG'-'lacZ, ΔaraBAD araC+, 
mal::lacIq, rne131::kan 
This study 
SA1750 PBAD-mut1-ATG'-'lacZ, ΔaraBAD araC+, 
mal::lacIq, rne131::kan 
This study 
SA1751 PBAD-mut2-ATG'-'lacZ, ΔaraBAD araC+, 
mal::lacIq, rne131::kan 
This study 
SA1752 PBAD-mut3-ATG'-'lacZ, ΔaraBAD araC+, 
mal::lacIq, rne131::kan 
This study 
SA1753 PBAD-mut4-ATG'-'lacZ, ΔaraBAD araC+, 
mal::lacIq, rne131::kan 
This study 
SA1754 PBAD-mut5-ATG'-'lacZ, ΔaraBAD araC+, 
mal::lacIq, rne131::kan 
This study 
SA1756 PBAD-mut6-ATG'-'lacZ, ΔaraBAD araC+, 
mal::lacIq, rne131::kan 
This study 
SA1757 PBAD-mut7-ATG'-'lacZ, ΔaraBAD araC+, 
mal::lacIq, rne131::kan 
This study 
Plasmid   
pBRCS12 pHDB3, PLlacO, vector control [151] 
pLCV1 pHDB3 PLlacO‐sgrSK12 [147] 
pBRCS22 pHDB3 PLlacO-sgrSSt [151] 
pSUB11 3xFLAG::FRT-kanR-FRT [145] 
pET21b-Hfq-
His6 
T7promoter-Hfq-(his)6 This study 
pLac-DicF pLac-DicF [5] 
pLac-DicF20 pLac-DicF20 (U41A, G42C) [5] 
pWKS30 PLlacO, vector control [155] 
pWKS30-SmS1 pLac-strong SD-mutated rpsA This study 
pWKS30-
WmS1 
pLac-weak SD-mutated rpsA This study 
pWKS30-WS1 pLac-weak SD-WT rpsA This study 
pWKS30-SS1 pLac-strong SD-WT rpsA This study 
pET28-rpsA T7 promoter –WT rpsA-thrombin site- (His)12 This study 









Table 2.2 Oligos used  
 
Oligo Description Sequence 5ˊ-3ˊ 
OSA178 Single-stranded oligo for 
recombineering manX 5ˊ UTR 





Reverse primer for 
recombineering manX (+39 nt 
into the coding region) 
TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACG
ACAGCCCAACCATGTGTGCCTATAAC 
OSA177 Single-stranded oligo for 
recombineering manX 5ˊ UTR 
with mutated Hfq binding site 
ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCC
ATTTAACGCGGCGGGAGGAGGTAGCAAGTGACCATTGC 
OSA433 Reverse primer for 
recombineering (manX with 19 












DicFW Single-stranded oligo with T7 
promoter for DicF in vitro 
transcription (Watson strand) 
TAATACGACTCACTATAGGGTTTCTGGTGACGTTTGGC
GGTATCAGTTTTACTCCGTGACTGCTCTGCCGCCC 
DicFC Single-stranded oligo for DicF in 
vitro transcription (Crick strand) 
GGGCGGCAGAGCAGTCACGGAGTAAAACTGATACCGCC
AAACGTCACCAGAAACCCTATAGTGAGTCGTATTA 
manYUTR Single-stranded oligo for 






mut1 Single-stranded oligo for 
recombineering mut1 manY 5ˊ 





mut2 Single-stranded oligo for 
recombineering mut2 manY 5ˊ 





mut3 Single-stranded oligo for 
recombineering mut3 manY 5ˊ 





mut4 Single-stranded oligo for 
recombineering mut4 manY 5ˊ 





mut5 Single-stranded oligo for 
recombineering mut5 manY 5ˊ 





mut6 Single-stranded oligo for 
recombineering mut6 manY 5ˊ 







Table 2.2 (cont.) 
 
Oligo Description Sequence 5ˊ-3ˊ 
mut7 Single-stranded oligo for 
recombineering mut7 manY 5ˊ 





mut9 Single-stranded oligo for 
recombineering mut9 manY 5ˊ 





mut10 Single-stranded oligo for 
recombineering mut10 manY 5ˊ 





mut14 Single-stranded oligo for 
recombineering mut14 manY 5ˊ 





mut15 Single-stranded oligo for 
recombineering mut14 manY 5ˊ 





OSA628 T7 forward primer for in vitro 
transcription of manY (-129 




OSA629 Reverse primer for in vitro 





Single-stranded oligo for 
recombineering manY 5ˊ UTR 




Δenh Single-stranded oligo for 
recombineering manY 5ˊ UTR 




mvENH Single-stranded oligo for 
recombineering manY 5ˊ UTR 




OSA003 T7 forward primer for in vitro 
translation of manY (-62 relative 
to the manY start codon) 
TAATACGACTCACTATAGGGCGTATTGTGTTGATTATC
ACTCAGTTTTC 
OSA823 Reverse primer for in vitro 






OSA321 T7 forward primer for in vitro 
translation of manY (-62 relative 





Table 2.2 (cont.) 
 
Oligo Description Sequence 5ˊ-3ˊ 
Y UTR lacZ 
SD 
Single-stranded oligo for 
recombineering manY 5ˊ UTR 




lacZ mut3 Single-stranded oligo for 
recombineering manY 5ˊ UTR 
(with lacZ SD and mut3 




lacZ mut5 Single-stranded oligo for 
recombineering manY 5ˊ UTR 
(with lacZ SD and mut5 




flip-enh Single-stranded oligo for 
recombineering manY 5ˊ UTR 






sSD Single-stranded oligo for 
recombineering manY 5ˊ UTR 





wSD Single-stranded oligo for 
recombineering manY 5ˊ UTR 





sSD+mut3 Single-stranded oligo for 
recombineering manY 5ˊ UTR 
(with a strong SD and the mut3 





wSD+mut3 Single-stranded oligo for 
recombineering manY 5ˊ UTR 
(with a weak SD and the mut3 





WT thrS Single-stranded oligo for 
recombineering thrS 5ˊ UTR (-66 






A-thrS Single-stranded oligo for 
recombineering thrS 5ˊ UTR with 
A-thrS (-66 to -1, relative to the 





G-thrS Single-stranded oligo for 
recombineering thrS 5ˊ UTR with 
G-thrS (-66 to -1, relative to the 





OSA734 T7 forward primer for in vitro 
translation of thrS (-66 relative to 







Table 2.2 (cont.) 
 
Oligo Description Sequence 5ˊ-3ˊ 
OSA753 T7 forward primer for in vitro 
translation of manY (-98 relative 
to the manY start codon, for 
ribosome footprint, and reverse 




OSA754 Reverse primer for in vitro 
transcription of manY (+98 
relative to the manY start codon, 
for ribosome footprint, and 
reverse transcription of DEPC-
modified transcripts) 
AGCGGACGGTGAAACTGAAATTC 
OSA786 Forward primer for 
recombineering sodB (+1, 




OSA787 Reverse primer for 
recombineering sodB (+120, 




OSA070 T7 forward primer for in vitro 




OSA071 Reverse primer for in vitro 
transcription and translation of 
gfp 
TACGTTTATTTGTAGAGCTCATCCATGCCATGTG 








OSA636 Forward primer for pET28 TTGATCTTTTCTACGGGGTCTGACGCT 
OSA637 Reverse primer for pET28 CTTCTTGAGATCCTTTTTTTCTGCGCGT 
OSA779 Primer to introduce Y205A, 




OSA780 Primer to introduce Y205A, 




OSA774 Forward primer with a strong SD 
to PCR amplify rpsA and mrpsA 
(to construct pWKS30-SS1) 
TTGTGAGCGGATAACAATTTTCACACATTGGAGGAACA
ATATGACTGAATCTTTTGCTCAACTCTTTGAAG 
OSA775 Forward primer with a weak SD 
to PCR amplify rpsA and mrpsA 
(to construct pWKS30-WS1) 
TTGTGAGCGGATAACAATTTTCACACATTCCAGGAACA
ATATGACTGAATCTTTTGCTCAACTCTTTGAAG 
OSA776 Reverse primer to PCR amplify 




OSA783 Forward primer for pWKS30 (for 
Gibson assembly) 
ACTGGCCGTCGTTTTACAACG 







Table 2.1 (cont.) 
 
Oligo Description Sequence 5ˊ-3ˊ 
OJH218 T7 forward primer for in vitro 
transcription of SgrS 
TAATACGACTCACTATAGGGGATGAAGCAAGGGGGTGC
CCCATG 
OJH169 Reverse primer for in vitro 































 In bacteria, the canonical mechanism of translational repression by small RNAs 
(sRNAs) involves sRNA-mRNA base pairing that occludes the ribosome binding site 
(RBS), directly preventing translation. In this mechanism, the sRNA is the direct 
regulator, while the RNA chaperone Hfq plays a supporting role by stabilizing the sRNA. 
There are a few examples where the sRNA does not directly interfere with ribosome 
binding, yet translation of the target mRNA is still inhibited. Mechanistically, this non-
canonical regulation by sRNAs is very poorly understood. Our previous work 
demonstrated repression of the mannose transporter manX mRNA by the sRNA SgrS, 
but the regulatory mechanism was unknown [110]. 
In this study, we explored the regulatory mechanism of two Hfq-dependent 
sRNAs, SgrS and DicF, that negatively regulate manX translation by an unconventional 
mechanism. The physiological condition that triggers expression of DicF is unknown, but 
SgrS is expressed during a metabolic state called glucose-phosphate stress [147]. 
Sugars are critical nutrients that fuel central metabolic pathways: glycolysis, the pentose 
phosphate pathway, and the TCA cycle, to generate precursor metabolites needed to 
synthesize nucleotides, amino acids, and fatty acids. Nonetheless, accumulation of 
excess phosphorylated sugar intermediates, and their non-metabolizable derivatives can 
be growth inhibitory [33, 71]. For instance, when cells are grown in the presence of non-
metabolizable sugar analogs, such as α-methyl glucoside (αMG) or 2-deoxy-D-glucose 
(2DG), it creates glucose-phosphate stress; glycolysis is inhibited, and cells stop 
growing [63, 147]. Under these conditions, E. coli induces expression of SgrS, an Hfq-
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dependent small RNA with regulatory activities that restore cell growth. When produced 
under glucose-phosphate stress conditions, SgrS base pairs with mRNA targets to 
regulate their translation and stability [13, 101, 110, 147]. One of the key activities of 
SgrS during glucose-phosphate stress is repression of mRNAs encoding 
phosphotransferase system (PTS) sugar transporters, ptsG [147] and manXYZ [109, 
110]. This repression inhibits new synthesis of PTS transporters and reduces uptake of 
sugars that are not being efficiently metabolized during stress. We have shown that base 
pairing-dependent repression of transporter synthesis by SgrS is required for continued 
growth under stress conditions [135]. 
Many sRNAs that repress gene expression do so by inhibiting translation 
initiation by preventing ribosome binding to target mRNAs. Since bacterial translation 
initiation requires RNA-RNA base pairing between the 16S rRNA and the SD region, 
sRNAs typically base pair with a site close to the SD region and compete with the 30S 
ribosomal subunit [127]. Initial research on the interaction between mRNA and the 
ribosome suggested that initiating ribosomes occupy ~40 nt, from -20 nt in the 5´ UTR to 
+19 nt into the coding region, where numbering is with respect to the start codon [10, 
54]. A study using synthetic antisense oligonucleotides tested the boundaries to define 
the region where a base pairing interaction could prevent formation of the translation 
initiation complex (TIC). This study indicated that oligos base pairing within 15 
nucleotides downstream of the start codon can inhibit TIC formation [17]. This led to the 
“five codon window” hypothesis that proposed that if an sRNA base pairs with 
nucleotides comprising the first five codons of the mRNA, it can directly inhibit binding of 
the 30S ribosomal subunit and repress translation initiation. Interestingly, some studies 
have uncovered apparent exceptions to this hypothesis where sRNAs repress 
translation, either directly or indirectly, by base pairing outside of the five-codon window 
[13, 28]. For example, the Massé group found that binding of the sRNA Spot 42 at a site 
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~50 nt upstream of the sdhC start codon. Their evidence suggested that the Spot 42 
itself does not directly compete with the initiating ribosome, but instead may recruit the 
RNA chaperone Hfq to bind near the sdhC ribosome binding site (RBS) and act as the 
primary repressor [28].  
In this study, we investigated the mechanism by which SgrS regulates the first 
cistron of the manXYZ operon, manX. We observed previously that regulation of manX 
mRNA by SgrS involves base pairing 20 nt downstream of the start codon, which lies 
outside the 5 codon window [110]. We also characterized regulation of manX translation 
by another sRNA regulator, DicF [5], a 53-nt long Hfq-dependent sRNA [35]. The DicF 
binding site on manX mRNA is even further downstream than the SgrS binding site. We 
hypothesized that each of these sRNAs regulates manX translation by a “non-canonical” 
mechanism, since their binding sites are positioned too far downstream for sRNA-mRNA 
base pairing to directly occlude ribosome binding. To test this hypothesis, we addressed 
several questions. Does sRNA-mRNA duplex formation directly inhibit translation by 
preventing formation of the translation initiation complex? If not, then is Hfq required for 
translational repression?  Does Hfq bind to the manX mRNA near the ribosome binding 
site? 
Our results demonstrate that Hfq is absolutely required for translational 
repression mediated by SgrS and DicF in vivo. In vitro, Hfq, but not the sRNAs, can 
specifically inhibit formation of the TIC on manX mRNA. RNA footprints confirmed that 
SgrS and DicF have distinct binding sites in the manX coding region, and both of these 
sRNAs facilitate Hfq binding at a site close to the RBS. Taken together, our data 
demonstrate sRNAs mediate regulation of manX translation by a non-canonical 
mechanism involving recruitment or stabilization of Hfq binding at a site where it can 





3.2.1 Hfq is essential for translational repression of manX  
Previously, we identified manXYZ mRNA, which encodes a mannose and 
(secondary) glucose transporter (EIIMan), as a target of SgrS [109, 110]. The polycistronic 
manXYZ mRNA is negatively regulated post-transcriptionally via two independent SgrS-
manXYZ mRNA base pairing interactions [109]. The physiological outcome of this 
regulation is repression of EIIMan transporter synthesis, which helps rescue cell growth 
during glucose-phosphate stress [110]. One of the SgrS binding sites was mapped to the 
coding region of manX, and this binding site was shown to be necessary for translational 
repression of manX [109, 110]. Although we have identified the base pairing sites for 
SgrS on the manXYZ transcript and established that translational regulation of this target 
is important for cell growth during glucose-phosphate stress, the exact mechanism of 
SgrS-mediated manX translational repression is unknown. The SgrS binding sites on the 
manXYZ mRNA are too far from the RBS of the manX and manY cistrons [109] to 
directly occlude ribosome binding (Fig. 3.1). We hypothesized that manX translation 
might be repressed by a non-canonical mechanism where Hfq serves as the direct 
repressor of translation while SgrS plays an accessory role, perhaps recruiting Hfq to 




Fig. 3.1:  Base pairing between A) SgrS and a canonical target ptsG, and B) SgrS and a 
non-canonical target manX. SgrS base pairs on the ribosome binding site shielding it 
from the initiating ribosome. SgrS, on the other hand, base pairs downstream into the 
manX coding region.  
 
To test this hypothesis, we first investigated whether translational repression of 
two different SgrS targets, ptsG and manX, was dependent on Hfq in vivo. Aiba and 
coworkers have already shown that SgrS can inhibit translation of ptsG in the absence of 
Hfq [76], consistent with the canonical model for repression where the sRNA pairs near 
the TIR and directly occludes ribosomes. Here, we utilized manX′-′lacZ and ptsG′-′lacZ 
translational fusions that we have already demonstrated are good reporters for SgrS-
dependent regulation of these targets [110]. We monitored fusion activities after SgrS 
production was induced in wild-type and Δhfq backgrounds. Since stability of E. coli 
SgrS (SgrSEco) is greatly reduced in the absence of Hfq [99], we utilized the Salmonella 
SgrS allele (SgrSSal) which is more stable than SgrSEco in the Δhfq background and has 
very similar seed region that allows it to efficiently regulate E. coli SgrS target mRNAs 
([6] and Fig.  3.2). In agreement with our previous study, we found that SgrSSal can 
complement a ΔsgrS mutant for regulation of manX (Fig. 3.3A) [6]. Consistent with the 
direct ribosome occlusion mechanism for translational regulation of ptsG, SgrSSal 
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efficiently repressed the ptsG′-′lacZ fusion in both the wild-type and Δhfq backgrounds 
(Fig. 3.3B). In contrast, while SgrS efficiently repressed manX in a wild-type background, 
it failed to repress the fusion in an hfq mutant background, even at high levels of inducer 
(Fig. 3.3C). These data indicate that SgrS cannot regulate manX in vivo in the absence 
of Hfq. 
 
Fig. 3.2: A) SgrSEco and B) SgrSSal do not share detectable sequence similarity. However, 
for manX, the seed regions and the anti-seed region these two homologs base pair with 






Fig. 3.3: A) Both Salmonella SgrS and E. coli SgrS can repress manX translation. A 




Fig. 3.3 (cont.) 
 
heterologous Cp-19 promoter. Both SgrSSal and SgrSEco were induced with a final 
concentration of 0.1 mM IPTG. The samples were grown for another 60 min and 
assayed for β-galactosidase activity. B) Translation repression of a canonical target in 
SgrS targetome, ptsG, can be achieved by SgrSSal in the absence of the pleotropic 
chaperone protein Hfq. β-Galactosidase activities in the samples were normalized to the 
levels the vector control strains to yield percentage relative activity. C) In the absence of 
Hfq, plasmid borne SgrSSal, even with 0.5 mM IPTG (final concentration), SgrS cannot 
repress manX translation in the absence of Hfq. 
 
If the role of SgrS in manX regulation is to recruit or enhance binding by the 
putative primary or direct regulator Hfq, it follows that Hfq should bind close to the manX 
TIR. To determine if there were elements in the 5′ UTR, such as a putative Hfq binding 
site, that were required for translational regulation, we constructed a series of manX 
translational fusions with truncations in the 5′ UTR (Fig. 3.4A). Activity of these fusions 
was measured in the presence and absence of ectopically expressed sgrS. The 
constructs contained 65, 30, 25, and 22 nt of the manX 5′ UTR region, and in the hfq+ 
background, all four fusions showed a similar pattern of regulation compared to the 
construct containing the full-length 115-nt manX 5′ UTR (Fig. 3.3A). Further truncation of 
the manX 5′ UTR was not possible without interfering with the RBS. Nevertheless, the 
fact that all truncated fusions were regulated similarly to wild-type suggested that the 
putative Hfq binding site resided downstream of the 5′  boundary defined by the 22-nt 
fusion (Fig. 3.4A). An A/U-rich motif just upstream of the manX RBS is similar to the 
motif that was shown in other studies to be preferentially bound by Hfq [38, 121]. To test 
the role of this motif in the regulation of manX translation, we constructed a mutant 
manX fusion where the A/U-rich motif was converted to a C/G-rich motif (Fig. 3.4B). In 
contrast with the wild-type manX fusion, which was efficiently repressed when SgrS was 
ectopically expressed, SgrS failed to alter translation of the mutated fusion (Fig. 3.4B). It 
is important to note that the A/U-rich putative Hfq binding motif is far upstream from the 
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known SgrS base pairing site (Fig. 3.4B). Thus, the loss of regulation in the mutant 
suggests that regulation of manX translation is not directly mediated by SgrS base 






Fig. 3.4: Genetic localization of hfq binding site A) Wild type manX UTR in E. coli is 115 
nt. Four translation fusions with decreasing lengths of UTR were constructed where the 
heterologous promoter was moved closer and closer to the TIR.  B) An A/U rich motif, 
right upstream of the manX RBS was mutated (mut-1, CGGCGGGA) and fused with 
lacZ (see text). In a hfq+ background, two lacZ translational fusion fusions- a 25 nt WT 
UTR and a mutated UTR, were assayed for β-galactosidase activity after SgrSEco 
expression from a plasmid. The specific activities, quantified in Miller units, were 
normalized to the vector control to yield relative activity values. The RBS is in blue 
letters, and the manX start codon is in green. C) Beta galactosidase assay of fusions of 
25 nt UTR-manX´-´lacZ with two nucleotides altered in the Hfq binding motif. The 
mutated Hfq motifs are shown below the X-axis. 
 
If this A/U rich motif is the true Hfq binding site, we envisaged that abrogation of 
translation repression should also be observed with fewer nucleotide changes.  We 
tested this prediction by constructing four strains, each harboring two nucleotide 
mutations (Fig.  3.4C). We noticed that the Hfq binding motif is too close to the RBS 
region and mutations in this motif is likely to change the expression and/or stability of the 
reporter gene. As expected, these two nucleotide mutations were sufficient to eliminate 
Fig. 3.4 (cont.) 
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Hfq binding, and we observed loss of SgrS mediated regulation in these mutated 
constructs (Fig. 3.4C). Interestingly, under two circumstances we noticed a drop in the 
basal activities of the lacZ reporter fusion- i) when hfq was deleted (Fig. 3.3C), and, ii) 
when the Hfq binding site was mutated (Fig. 3.4B, 3.5A).The Hfq binding site is next to 
the RBS, and it is not surprising that mutations in this motif could cause altered 
translation rate. If that is the case, then it is crucial to demonstrate that the loss of 
regulation results from the lack of Hfq binding and not due to low translation rate. To 
investigate this, we assayed beta-gal activities of the lacZ fusions containing two 
nucleotide mutations in the Hfq binding motif (Fig. 3.5B). Two constructs, containing 
ATAATAGG and ATGGTAA motifs, showed similar basal reporter activity as the wild 
type (Fig. 3.5B) and these two mutations also abolished SgrS mediated repression (Fig.  
3.4C). These data suggest that the lack of Hfq binding, not the altered translation rate of 
the mutant, abrogates SgrS mediated regulation of the fusions. Next, we asked whether, 
in the absence of hfq, the drop in the fusion activity is the outcome of reduced stability of 
the transcript. To test this possibility, we measured the lacZ fusion activities of the 
constructs mentioned above in the rne131 background. Interestingly, the beta gal activity 
does not drop when the strains harbored hfq::cat allele suggesting that in the absence of 
Hfq, manX transcript becomes unstable in a RNase E-dependent manner (Fig. 3.5B). 
This is an exciting finding, and we plan to investigate the effect of the RNase E-Hfq 




Fig. 3.5: Hfq impact translation and stability of manX mRNA. A) The basal β-gal activity of 
the manX´-´lacZ fusions with WT (ATAATAA) and mutated binding motifs, in presence or 
absence of Hfq. B) The beta galactosidase activities of the WT and the mutated motif 





3.2.2 Hfq inhibits formation of the translation initiation complex on manX mRNA 
If Hfq is the direct repressor of manX translation it should compete with the 
ribosome for binding to the mRNA in vitro. We used toeprinting assays [36] to test 
whether Hfq or SgrS could directly inhibit translation initiation. In a toeprinting assay, 
stable binding of the 30S ribosomal subunit and tRNAfMet to the RBS blocks a primer 
extension reaction and produces a product with a characteristic size. Since native manX 
has a weak GTG start codon that does not stably associate with commercially available 
preparations of 30S ribosomes, we changed the start codon to the canonical ATG to 
ensure strong initiation complex formation in vitro. We showed previously that this 
construct, manXATG, was efficiently repressed by SgrS [110]. The toeprint assay was 
performed by mixing manXATG mRNA, P32 end-labeled primer, ribosomes, and tRNAfMet 
in the presence and absence of Hfq. Reverse transcriptase was then added to begin the 
primer extension reaction. In the positive control reaction, we saw the characteristic 
toeprint signal caused by termination of reverse transcription at position +15/+16 relative 
to the start codon (Fig.  3.6A). With the addition of increasing concentrations of Hfq, the 
formation of the TIC was completely inhibited (Fig.  3.6A and 3.6B). However, when 
increasing concentrations of SgrS were added in the absence of Hfq, TIC formation was 
unperturbed (Fig.  3.6B). When the same concentrations of SgrS was added to a toeprint 
reaction using ptsG as a template, we observed inhibition of the toeprint signal (Fig. 
3.6C). These results are consistent with the in vivo studies, and add further evidence 





Fig. 3.6: Repression of the manX translation initiation complex formation by Hfq, lane 4, 
5, and 6 (0.15 µM, 0.5 µM, and 1 µM). A) Hfq alone, in the absence of SgrS, can prevent 
manX translation initiation complex formation. Sequencing ladders, indicated by TGCA, 
were generated with the same oligo OJH119. The toeprint signal is indicated +15/16 
relative to the start codons. B) Increasing amount of hfq was able to inhibit the initiation 
complex formation, whereas SgrS was not (100 nM, 250 nM, and 500 nM). Addition of 
ribosome and initiator tRNA is indicated by ‘+’ symbol. C) Repression of the ptsG 
translation initiation complex formation by SgrS, lane 4, 5, and 6 (100 nM, 250 nM, and 
500 nM respectively). SgrS alone is able to prevent ptsG translation initiation complex 
formation. Sequencing ladders, indicated by TGCA. The toeprint signal is indicated +16 
relative to the start codons.  
 
3.2.3 manX is regulated by DicF sRNA 
In a previous study, manX was identified as a putative target of another sRNA, 
DicF [5]. To further investigate the regulation of manX by DicF and determine the 
regulatory mechanism, we monitored the activity of a manX'-'lacZ translational fusion 
(under the control of a constitutive promoter to rule out indirect effects on manX 
transcription) in control cells and cells where DicF was ectopically expressed. Cells 
expressing dicF showed ~40% reduced β-galactosidase activity compared to control 
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cells (Fig. 3.7A). Compared to SgrS, which reduces manX translation by about 70% (Fig.  
3.4B), DicF is a rather weak regulator.  
Previous studies have demonstrated that sequences at either the 5′ or the 3′ end 
of DicF can base pair with mRNA targets [5, 141]. We identified a potential base pairing 
interaction between the 3′ end of DicF and the coding region of manX just downstream 
of the known SgrS binding site (Fig. 3.7B). To test this base pairing prediction, we made 
a mutation in nucleotides of DicF that should disrupt the base pairing interaction (Fig. 
3.7B). This mutant allele, dicF20, lost the ability to regulate the manX'-'lacZ translational 
fusion (Fig. 3.7C), consistent with the base pairing prediction. If DicF also base pairs 
within the manX coding sequence, well outside the window that would allow direct 
interference with ribosome binding, then like SgrS, DicF may also repress manX 
translation by influencing Hfq binding in the manX TIR. To test whether DicF-mediated 
regulation requires the putative Hfq binding site near the RBS, we constructed a mutant 
version of the manX'-'lacZ fusion (containing the putative DicF base pairing site) where 
the A/U-rich region next to the RBS is changed to G/C-rich (mut6). In contrast with the 
wild-type manX fusion, which was repressed upon dicF expression, activity of the mut6 
fusion with the mutation in the putative Hfq binding site was not altered by DicF (Fig. 
3.7A). This observation is consistent with the model that DicF-mediated regulation of 
manX is similar to SgrS in that it requires Hfq binding proximal to the RBS where it acts 




Fig. 3.7:  DicF, a prophage encoded sRNA, also regulates manX translation. A) β-
Galactosidase assays using manX’-‘lacZ fusions with WT (JH175) and mutated Hfq 
binding site containing UTRs (SA1620) under the control pf pBAD promoter. The specific 
activities were normalized to the corresponding empty vector control values to yield 
percent relative activity. B) The pairing sites of SgrS and DicF on the manX mRNA. Both 
sRNAs pair into an overlapping region downstream of the manX start codon. C) 
Mutations in DicF (dicF20) disrupt complementarity and regulation. 
 
3.2.4 Hfq binds next to the manX ribosome binding site 
We predicted that DicF base pairs at a site just downstream of the SgrS binding 
site, from residues G145 to C162 (Fig. 5B). Our genetic analyses suggest that Hfq binds 
in the 5’ UTR just upstream of the RBS to act as the direct repressor of manX translation 
for both SgrS- and DicF-mediated regulation (Figs 3.4B and 3.7A). To further test this 
prediction, we performed in vitro footprinting experiments with labeled manX RNA to 
identify the Hfq binding site(s) occupied in the presence of each individual sRNA. As we 
showed previously, SgrS protects its binding site from C139 to G152 on manX mRNA 
even in the absence of Hfq, and the addition of Hfq does not change the footprint (Fig. 
3.8A) [110]. Notably, SgrS alone does not affect the structure around the RBS or start 
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codon. Consistent with our prediction (Fig. 3.8B), DicF protects manX mRNA from G150 
to C167 in the absence and presence of Hfq. Again, DicF only impacted the reactivity of 
nucleotides comprising its binding site in the manX coding region, and the structure 
upstream in the TIR was unaffected. In the presence of either sRNA, Hfq clearly 
protected manX mRNA nucleotides A97-A103 (Fig. 3.8A). Note that this region is the 
same A/U-rich region that we predicted as the Hfq binding site (Fig. 3.8B) and that when 
mutated, prevented SgrS- and DicF-dependent regulation (Figs. 3.4B and 3.7A, 
respectively). Additionally, we observe some weak protections for residues U91-C95. 
These findings demonstrate that Hfq binds at precisely the same location on manX 
mRNA, adjacent to the RBS, regardless of which sRNA is present in the sRNA-mRNA-
Hfq ternary complex.  
Now, this leads to a broader question regarding the nature of the secondary role 
played by the sRNA when the regulation happens in a role-reversal fashion. Ectopically 
expressed Hfq does not inhibit manX translation in the absence of the sRNA partner 
(data not shown). We envisaged that the presence of the sRNA partner could be 
essential if it functions as a guide to change the affinity of Hfq for the manX transcript. To 
test this possibility, we performed the footprint with a low concentration of Hfq in 
presence and absence of SgrS, and in agreement with our conjecture, we observed the 
protection by Hfq only when SgrS was present in the reaction (Fig. 3.8C). We used a 
mutated manX transcript where the binding motif was changed to CGGCGGG, and we 
did not observe any Hfq mediated protection, even in the presence of SgrS confirming 









Fig. 3.8: Footprinting to map SgrS, DicF and Hfq binding sites on manX RNA. A) In vitro 
transcribed manX mRNA containing 115 nt UTR and the coding region containing 51 
bases past the predicted DicF base pairing region was end labeled with P32 and 
incubated with unlabeled SgrS and Hfq to perform footprinting reactions. T1 indicates 
RNase T1 ladder; OH, alkaline ladder; PbAc, lead acetate. Interaction between 
DicF:manX and Hfq-manX were mapped as described above. B) Putative structure of 
manX following interaction with Hfq and SgrS or DicF. C-D) Footprinting to investigate 
Hfq recruitment in presence or absence of SgrS with WT(ATAATAAA) Hfq binding motif 




Fig. 3.8 (cont.) 
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3.2.5 DicF is a weaker regulator of manX 
 Compared to DicF, SgrS is a stronger repressor of manX translation (compare 
repression in Fig. 3.4B to Fig. 3.7A). Our data suggest that each of these sRNAs 
mediates translational regulation indirectly, via facilitating or stabilizing Hfq binding to a 
site in the 5′ UTR adjacent to the RBS (Fig. 3.8A). To explore the basis for the different 
efficiencies of regulation, we conducted experiments to measure the affinity of sRNA-
mRNA interactions and sRNA-Hfq interactions. We reasoned that differences in the 
binding affinity of the sRNAs for manX mRNA and/or Hfq, could be important 
determinants of regulatory efficiency for each sRNA-mRNA-Hfq interaction. 
Electrophoretic mobility shift assays (EMSAs) were used to measure the specific binding 
of SgrS and DicF individually to manX mRNA in vitro. We found that SgrS base paired 
with manX mRNA, with a dissociation constant KD of 4.53 µM (Fig. 3.9A). DicF 
interacted less strongly with manX mRNA, with a KD of 21.8 µM (Fig. 3.9A). The higher 
KD for DicF-manX mRNA is consistent with our observation that compared to SgrS, DicF 
is a weak repressor of manX translation. In a previous study, we found that in vivo, the 
KD for SgrS binding to full-length manXYZ mRNA (with both manX and manY binding 
sites) was 2.3 µM [37]. Thus, our in vitro measurement is in good agreement with the in 
vivo data for SgrS. 
EMSAs to monitor interactions of each sRNA with Hfq also revealed differences 
between SgrS and DicF. The Hfq-SgrS interaction was relatively strong, with a 
calculated KD of 3.37 nM (Fig. 3.9B).  Hfq bound DicF less tightly with a calculated KD of 
22.0 nM (Fig. 3.9B). The dissociation constant values we calculated for Hfq and SgrS or 
DicF are in a similar range as those reported previously for the binding of Hfq to OxyS, 
RyhB, DsrA, and Spot 42 sRNAs [42, 89, 126, 166]. Taken together, our data suggest 
that SgrS is a more efficient regulator of manX translation than DicF and that differences 
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in sRNA-mRNA binding interactions and sRNA-Hfq interactions could influence the 
efficiency of regulation.  
 
Fig. 3.9:  A) Native gel electrophoresis assay to examine the difference in binding of the 
manX mRNA with SgrS and DicF sRNAs.In vitro transcribed labeled manX mRNA (0.01 
pmol) was mixed with indicated amount of cold SgrS and incubated at 370C for 30 min. 
The reaction mixture was resolved on a chilled native acrylamide gel. B) Gel mobility 
shift assay for SgrS and DicF. SgrS has higher affinity for Hfq. Measured band densities 




Our study shows that two sRNAs, SgrS and DicF, base pair with manX mRNA at 
distinct sites in the coding region, outside the window that would allow translational 
repression via a direct ribosome occlusion mechanism. Instead, we propose that Hfq 
acts as the direct regulator of manX translation and that the sRNAs play an accessory or 
secondary role. This model is supported by multiple lines of evidence presented in this 
study. In vivo, SgrS cannot repress manX translation in the absence of Hfq (Fig. 3.3C). 
This is in contrast with regulation of another SgrS target, ptsG, which is known to occur 
via the canonical (direct) mechanism of translational repression [59, 147]. SgrS 
efficiently represses ptsG translation in an hfq mutant background (Fig. 3.3B). Loss of 
regulation by both sRNAs is seen in an hfq+ background when the Hfq binding site 
upstream of the manX RBS is mutated (Figs 3.4B, 3.7A). Structural analyses clearly 
demonstrate that SgrS and DicF bind to sites in the coding region of manX mRNA and 
have no impact on the structure near the TIR. In contrast, in the presence of either SgrS 
or DicF, Hfq binds to the same site on manX mRNA, directly adjacent to the RBS (Fig. 
3.8A). The mapped Hfq binding site is also in agreement with previously published high-
throughput studies [81, 143]. Differences in the relative strength of manX translational 
regulation promoted by SgrS and DicF were correlated with the strength of sRNA-mRNA 
and sRNA-Hfq interactions (Fig. 3.9A, B). Collectively, our data are consistent with a 
non-canonical mechanism of regulation where the sRNAs play a guide-like role in 
regulation by promoting Hfq binding to a site near the manX RBS so that Hfq itself 
directly interferes with ribosome binding (Fig. 3.10). This model is in stark contrast to the 
canonical model of bacterial sRNA-mediated translational repression where sRNAs are 
the direct competitors of ribosome binding, while the chaperone Hfq assumes the 




Fig. 3.10: A model for the non-canonical roles played by two distinct sRNAs, SgrS and 
DicF, to repress manX translation in a Hfq dependent mechanism. 
 
 A recent study reported a non-canonical mode of translation regulation where the 
sRNA Spot 42 binds its target sdhC mRNA far upstream of the RBS. Spot 42 itself 
cannot compete with the incoming ribosome for binding to sdhC mRNA, but instead 
seems to facilitate binding of Hfq to a site near the TIR in order to block translation 
initiation [28].  Another study by Blasi and colleagues also reported that in the absence 
of any sRNA, Hfq causes translation repression of ompA mRNA where Hfq competes 
with the 30S ribosomal subunit [150]. Here, we show that sRNAs can employ similar 
mechanism and recruit Hfq to bind near the RBS even if they base pair downstream in 
the mRNA coding region. Footprinting of manX mRNA with SgrS, DicF, and Hfq 
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revealed that SgrS base pairs with nucleotide +24 to 36 on the manX transcript, while 
DicF base pairs little downstream, with nucleotides +34 to +51, but both sRNAs recruit 
Hfq at the same location near RBS (Fig. 3.8). In other words, the identity and the 
location of base pairing sites do not seem to be the determining factor for non-canonical 
sRNA-based regulation effected by Hfq binding near the TIR. We propose that the 
sRNAs carry out the task of substrate recognition that subsequently allows the protein 
partner to be recruited at a particular binding site (Fig. 3.8C). Similar mechanisms are 
widely utilized by prokaryotic CRISPR guide RNAs, and eukaryotic non-coding RNAs, 
including small interfering RNAs, microRNAs, and small nucleolar RNAs. All of these 
types of RNAs act as a part of a ribonucleoprotein complex where the RNA component 
recognizes the substrate nucleic acid while the protein component performs catalysis.  
 Regulation of manX translation by DicF, an sRNA encoded on the cryptic 
prophage Qin on the E. coli chromosome, was confirmed in this study. Like other small 
RNAs encoded on horizontally acquired genetic elements like prophages and 
pathogenicity islands, DicF is poorly characterized. However, research over the last 
decade, suggests that horizontally-acquired sRNAs are crucial regulators of bacterial 
physiology, growth, and stress responses [49, 100, 105]. For instance, the sRNA InvR, 
encoded in Salmonella pathogenicity island 1, is a major regulator of outer membrane 
porin OmpD [103]. IpeX, an sRNA encoded on the cryptic prophage DLP12 in E. coli, is 
a regulator of outer membrane porins, OmpC and OmpF [20]. DicF was identified in the 
1980s when it was observed to cause a filamentation phenotype when expressed from a 
multi-copy plasmid [16]. We recently demonstrated that DicF directly regulates 
translation of mRNA targets encoding diverse products involved in cell division and 
metabolism [5]. These include mRNAs encoding the tubulin homolog FtsZ, xylose 
uptake regulator XylR, and pyruvate kinase PykA [5, 141]. Our current study extends the 
DicF targetome to include manX. Though SgrS and DicF share a common target in 
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manX, these sRNAs are not expressed under the same conditions. We did not see DicF 
expression when cells were challenged with αMG or 2DG (data not shown). Under 
standard laboratory growth conditions, the dicBF operon is not expressed, and we do not 
yet know the signal that triggers the expression of this operon. Further research aimed at 
uncovering the physiological conditions stimulating DicF production may provide insight 























TRANSLATION INHIBITION FROM A DISTANCE: SgrS SILENCES A TRANSLATION 
ENHANCER IN THE LEADER REGION 
 
4.1 Introduction 
 Microbes respond to changes in environmental conditions using a variety of 
mechanisms to modify gene expression resulting in changes in cell structure and 
function. Small RNAs (sRNAs) are found in microbes across the tree of life and are 
major regulators responsible for post-transcriptional control of gene regulation. sRNAs 
regulate target mRNA translation and stability by a variety of molecular mechanisms that 
depend on sRNA-mRNA duplex formation. Early studies characterizing sRNA-mRNA 
interactions reported sRNA base pairing with sequences around the Shine-Dalgarno 
(SD) sequence [86, 119]. In vitro structure probing of sRNA-mRNA duplexes and 
toeprinting assays probing translation initiation complex formation [2, 17, 42, 89], have 
revealed that a common mechanism of sRNA-mediated translational repression is steric 
occlusion of ribosome binding. However, a growing number of examples of translational 
repression by sRNAs involve base-pairing interactions far from the SD sequence [3, 28, 
52, 123]. Several mechanisms have been reported for regulation of translation via 
sRNA-mRNA duplex formation distant from ribosome binding sites. Th90e first involves 
sRNA binding at a site upstream or downstream of the translation start resulting in 
recruitment of the RNA chaperone Hfq to bind at a site near the SD so that Hfq occludes 
ribosome binding [3, 28]. Another mechanism involves sRNA sequestration of CA-rich 
sequences that act as translation enhancer elements [123, 162]. The sRNA GcvB 
represses translation of several mRNAs using a GU-rich seed region that base pairs with 
CA-rich target sites located at variable distances upstream of the SD. In the absence of 
GcvB, the CA-rich sequences enhance mRNA translation by an unknown mechanism. 
With GcvB present, these enhancer sequences are sequestered and translation of 
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mRNA targets is reduced. A third mechanism of sRNA-mediated translational repression 
from a distance involves ribosome standby sites. Certain mRNAs with stable secondary 
structures around the ribosome binding site use upstream ribosome standby sites to 
promote translation. Ribosome standby sites are located in single-stranded regions 
where a 30S ribosomal subunit can bind and kinetically compete with RNA folding to 
access the downstream translation initiation region [25, 128, 131]. The toxin-encoding 
tisB mRNA has a ribosome standby site far upstream of the SD, and this site can 
promote translation of tisB only in the absence of an antisense sRNA, IstR, which 
sequesters the standby site [24, 114]. These examples illustrate the many mechanisms 
of translational repression mediated by sRNAs binding to mRNAs within and outside the 
translation initiation region. 
 The rate-limiting step in protein synthesis is generally considered to be binding of 
the small ribosomal subunit to the mRNA upstream of the start codon to form the 
translation initiation complex [64, 84]. In most cases, the mRNA leader region contains a 
purine-rich SD sequence [124] just upstream of the start codon that forms a short duplex 
with the 3'-end of the 16S rRNA (anti-SD sequence). Some leader regions may contain 
additional sequence features that can also determine the rate of translation initiation 
[85]. Pyrimidine-rich sequences that are sometimes present immediately upstream of the 
SD can interact with the 30S subunit ribosomal protein S1 and act as translational 
enhancers [14, 15, 31]. For these mRNAs, formation of the preinitiation complex involves 
RNA-RNA interactions and RNA-protein interactions that both contribute to the efficiency 
of translation initiation [31, 78, 137]. sRNAs could interfere with translation initiation by 
disrupting any of the interactions – RNA-RNA or RNA-protein – that are important for 
formation of the translation initiation complex. 
In this study, we aimed to define the molecular mechanism by which an E. coli 
sRNA, SgrS, regulates translation from a distance. SgrS represses translation of all the 
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cistrons encoded by the manXYZ mRNA, which encodes the mannose PTS transporter 
[109, 110]. SgrS binds to two distinct sites on manXYZ mRNA [3, 109, 110]. The first site 
is located within the manX coding sequence, and we showed recently that SgrS 
represses translation of manX via a non-canonical mechanism involving SgrS-
dependent recruitment of Hfq to a binding site that overlaps the manX SD sequence – 
making SgrS the chaperone-like partner and Hfq the direct repressor of translation [3]. 
SgrS base pairs at a second site in the manX-manY intergenic region, 30 nucleotides 
upstream of the manY start codon (Fig. 4.1A). SgrS binding at this site represses manY 
and manZ translation (manZ translation is coupled to that of manY) by an unknown 
mechanism [109]. The manY binding site is outside the -20 to +20 (relative to the start 
codon) region protected by the translation initiation complex [10, 17, 54] suggesting that 
the mechanism of regulation by SgrS is not the canonical mechanism of occlusion of the 
SD sequence.   
Here, we probed the roles of Hfq, SgrS and the ribosome, particularly ribosomal 
protein (r-protein) S1, in modulating the translation of manY. We found that Hfq is 
required for SgrS-dependent regulation of manY, not only because it stabilizes SgrS [6], 
but also because it promotes SgrS-manY mRNA duplex formation. We discovered that 
the AU-rich sequences that comprise the SgrS binding site upstream of manY act as a 
translational enhancer. The enhancer promotes higher levels of translation independent 
of whether the SD is strong or weak. We performed genetic and biochemical 
experiments that provide evidence for ribosomal protein S1 binding to the enhancer 
sequence to make the manY SD more accessible. Our data are consistent with the 
model that manY translation is controlled by an r-protein S1-dependent enhancer, and 
SgrS represses translation by interfering with S1 binding to the enhancer sequence, 






Fig. 4.1: SgrS-dependent regulation of manY translation requires Hfq. A) A model 
showing the two SgrS binding sites on manXYZ mRNA. B) SgrS base pairing at the site 
in the manX-manY intergenic region, 30 nt upstream of the manY start codon. C) Wild-
type (SA1747) and hfq::kan (SA1907) strains harboring a manY'-'lacZ translational 
fusion (under the control of a PBAD promoter) were transformed with a vector or plasmid 
containing one of two SgrS orthologs –  SgrSEco from E. coli, or SgrSSal from Salmonella. 
Cells were grown and β-Galactosidase assays were performed as described in the 
Materials and Methods. Error bars represent standard deviation from three biological 
replicates. P values (unpaired t test) are shown as: *, P < 0.05; **, P < 0.005; ***, P < 




4.2.1 Hfq is essential for translation repression of manY 
During glucose-phosphate stress, translation of the manXYZ operon is repressed 
by SgrS via base pairing interactions at two distinct sites on manXYZ mRNA (Fig. 4.1A) 
[3, 109, 110]. The base pairing interaction between SgrS and the manX-manY intergenic 
region (Fig. 4.1A, 4.1B) is 30 nucleotides upstream of the manY start codon [109]. 
Previous studies [10, 17, 54] have suggested that base pairing interactions outside the -
20 to +20 window (relative to the start codon) cannot regulate translation by steric 
occlusion of ribosome binding, so the precise mechanism of SgrS-mediated translational 
repression of manY has remained unknown. To investigate the molecular details of the 
SgrS-manY interaction, we first looked at the role of the RNA chaperone Hfq [68, 89, 
166]. For these experiments, we used a manYʹ-ʹlacZ translational reporter fusion 
construct described previously [110] that contains only the SgrS binding site in the 
manX-manY intergenic region (Fig.  4.1C). We monitored activity of the fusion in wild-
type and Δhfq host strains carrying SgrS expression plasmids. Previously, we showed 
that the stability of E. coli SgrS (SgrSEco) is reduced in the absence of hfq, but 
Salmonella SgrS (SgrSSal), which has a similar seed region and demonstrates 
comparable effectiveness in regulating targets in E. coli, is more stable in a Δhfq 
background [6]. Consistent with our previous studies [3, 6], in a wild-type host, both 
SgrSEco and SgrSSal repressed manYʹ-ʹlacZ fusion activity to less than 50 % of the activity 
in vector control cells (Fig. 4.1C). In the Δhfq background, the basal level of manYʹ-ʹlacZ 
activity was reduced, and neither SgrSEco nor SgrSSal repressed translation of manYʹ-
ʹlacZ further (Fig. 4.1C).  
To test whether Hfq is required to promote annealing between SgrS and manY 
mRNA, we performed footprinting reactions in the presence and absence of Hfq. End-
labeled manY transcripts incubated with and without SgrS and Hfq were subjected to 
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enzymatic (with RNase T1) and chemical (lead acetate) digestion. We performed an 
SgrS-manY footprinting experiment by mixing denatured end-labeled manY mRNA and 
unlabeled SgrS (with or without Hfq), followed by incubation under conditions that allow 
for annealing and then digestion. Using this procedure, we observed SgrS-dependent 
protection in the absence of Hfq (Fig. 4.2A, compare lanes 3 and 4) and in the presence 
of Hfq (Fig. 4.2A, lanes 5 and 6). The protection covered residues -30C to -44A (Fig.  
4.2A, numbering relative to start codon), with hypersensitivity of the three U residues (-
36U to -38U) in the center of the base pairing interaction that are not involved in duplex 
formation (Fig. 4.1B). These results are perfectly consistent with the SgrS binding site on 




Fig. 4.2: Hfq promotes duplex formation between SgrS and manY mRNA. A) 
Footprinting assays were performed using in vitro transcribed labeled manY mRNA 
mixed with SgrS and then denatured prior to addition of binding buffer and varying 




Fig. 4.2 (cont.) 
RNase T1 digestion, Lane 2 – “OH” – contains the ladder generated by alkaline 
hydrolysis, and lanes 3-9 – “PbAc” – are lead acetate digested samples. Nucleotides 
protected by SgrS are labeled on the right. B) Footprinting assays were performed using 
in vitro transcribed – non-denatured – labeled manY mRNA mixed with SgrS and varying 
concentrations of Hfq. Lanes are labeled as described for part A. C) EMSAs using native 
gel electrophoresis were performed with P32 labeled manY and unlabeled SgrS that were 
hybridized in a binding buffer without prior denaturation. The samples were resolved in a 
chilled native acrylamide gel. Error bars represent standard deviation from (n=2) 
replicate experiments. D) EMSAs for SgrS and manY in the presence of Hfq. Hfq was 
removed by phenol extraction prior to running samples on a chilled native acrylamide 
gel. Error bars represent standard deviation from (n=3) replicate experiments. For both C 
and D, the measured band densities were plotted using the GraphPad Prism software to 
calculate the dissociation constants. 
 
We next conducted footprinting experiments where SgrS and manY RNAs were 
not denatured prior to annealing and chemical probing (Fig. 4.2B). Under these 
conditions, we did not see SgrS-mediated protection of manY mRNA in the absence of 
Hfq (Fig. 4.2B, compare lanes 3 and 4) or when Hfq was present in the annealing 
mixture at lower concentrations (Fig. 4.2B lanes 5 and 6). In contrast, when Hfq was 
present at a higher concentration, we observed SgrS-dependent protection of manY 
mRNA over the known binding site – from residues -30C to -44A (Fig. 4.2B, lane 7).  
When reactions were performed using a limiting amount of Hfq and increasing amounts 
of SgrS (Fig. 4.2B, lanes 9, 10, and 11), we did not see protection.  Thus, the 
requirement for Hfq to promote SgrS-manY mRNA interactions under these conditions 
could not be overcome by increasing concentrations of SgrS. 
The data presented so far suggest that Hfq facilitates intermolecular SgrS-manY 
mRNA base pairing. To corroborate this finding, we conducted a set of electrophoretic 
mobility shift assays (EMSAs) to quantify SgrS-manY RNA interactions in the presence 
and absence of Hfq. For these experiments, in vitro transcribed manY and SgrS RNAs 
were mixed in a binding buffer without a prior denaturation step. We found that in the 
absence of Hfq, SgrS formed a complex with manY mRNA with a KD of 7.1 µM (Fig. 
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4.2C). When end-labeled manY RNA was incubated with increasing amounts of SgrS 
and equimolar concentrations of Hfq (which was subsequently removed by phenol 
extraction before the samples were resolved in native polyacrylamide gels), we obtained 
a KD of 0.7 µM, 10-fold lower than in the absence of Hfq (Fig. 4.2D). Altogether, the data 
suggest that Hfq promotes SgrS-mediated regulation of manY translation by facilitating 
SgrS-manY duplex formation. 
4.2.2 The manY translation initiation region contains a ribosome-dependent 
enhancer 
SgrS acts as a translational repressor by binding at a site upstream of the two 
major determinants of ribosome binding – the Shine Dalgarno (SD) and initiation codon. 
We hypothesized that the region bound by SgrS might be a translation enhancer, similar 
to those described in mRNA targets of other sRNAs [123, 162]. To test the role of the 
putative enhancer located within the SgrS binding site, we constructed a set of lacZ 
translational fusions. These fusions were driven by a heterologous promoter (PBAD), and 
contained the manX-manY intergenic region, including the SgrS binding site (Fig. 4.3A, 
green region). The wild-type fusion had a high basal level of activity at ~4000 Miller Units 
(Fig. 4.3A, “WT”). The fusion lacking the SgrS binding site and putative enhancer had a 
greatly reduced basal level of activity (Fig. 4.3A, “Δenh”), consistent with the idea that 
this sequence has a stimulatory effect on manY translation. A third fusion where the 
putative enhancer was moved downstream of the ATG (maintaining the reading frame) 
had similarly low activity (Fig. 4.3A, “ATGenh”), suggesting that the translation 
stimulatory effect of this sequence is position-dependent.   
To determine whether the enhancer activity of the region upstream of manY 
requires cellular factors other than the translation machinery itself, we performed in vitro 
translation assays with 3XFLAG-tagged manY transcripts. The amount of ManY-
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3XFLAG protein produced from wild-type transcripts containing the enhancer sequence 
in the 5' UTR was substantially more than the protein produced from an equivalent 
amount of Δenh transcripts (Fig. 4.3B). These results suggest that the enhancer activity 
of the sequences upstream of manY is not dependent on Hfq, RNase E, or other cellular 
factors. Instead, we propose that the enhancer can stimulate translation of manY directly 
through interaction with the ribosome.  
 
Fig. 4.3: The translation enhancer is ribosome-dependent. A) Activities of three manY'-
'lacZ fusions were compared to assess the regulatory role of the putative enhancer 
sequence. All fusions are controlled by the heterologous PBAD promoter. “WT” contains 
the wild-type manX-manY intergenic region with the enhancer sequence (indicated by 
the green box) positioned ~30 nt upstream of the manY start codon. “Δenh” contains a 
deletion of the enhancer sequence, “ATGenh” has the enhancer sequence deleted from 
the upstream region and replaced just downstream of (and in frame with) the start 
codon. Strains containing fusions were grown for 2 hr until reaching the mid-log phase 
and β-galactosidase assays were performed. Error bars represent standard deviation 
from three biological replicates. P values (unpaired t test) are shown as: *, P < 0.05; **, P 





Fig. 4.3 (cont.) 
 
were performed for 30 minutes using manY-3XFLAG transcripts. “WT” is wild-type 
enhancer sequence and “Δenh” contains a deletion of the enhancer sequence (as in part 
A). Products of translation were detected by Western blot using anti-FLAG and anti-GFP 
antibodies. As a control, reaction mixtures from each tube were analyzed on an SDS-
polyacrylamide gel and stained with Coomassie Blue (the band for EF-Tu is shown). 
 
 
4.2.3 Genetic analysis of enhancer sequences 
The putative enhancer region is U-rich (Fig. 4A, -28 to -29 and -35 to -38), similar 
to the motifs found in previous studies that interact with the small ribosomal subunit [15, 
31, 78, 137]. We also noticed a “CACA” motif, similar to those reported to act as 
translation enhancers in other sRNA target mRNAs [123, 162]. To further characterize 
the sequence determinants of the putative enhancer, we constructed reporter strains 
derived from the WT manY'-'lacZ fusion, each with different nucleotide substitution 
mutations in the putative enhancer region (Fig. 4.4A). Mutations in the U residues of the 
putative enhancer had the strongest effect on the basal levels of translation. Changing -
37U and -38U to G residues (Fig. 4.4A, B, mut1) reduced activity by ~30%. Mutation of -
35U and -34U to G residues (Fig. 4.4A, B, mut2) had no effect on activity, but mutation 
of all four U residues to G residues (Fig. 4.4A, B, mut3(G)) reduced activity of the fusion 
by ~85% compared to the wild-type fusion. Importantly, mutation of the U residues from -
35 to -38 to A residues (Fig. 4.4A, B, mut5(A)) yielded a fusion with activity equivalent to 
the wild-type fusion. Mutation of U residues at positions -28 and -29 to G residues also 
had a strong impact on basal levels of activity (Fig. 4.4A, B, mut4). Other mutations in 
this putative enhancer region, including residues in the “CACA” motif, had no effect on 
basal levels of translation (Fig. 4.4A, B, mut6, mut7, mut9, mut10, mut14, mut15). These 
results suggest that U and A residues in this region are particularly important for the 

















Fig. 4.4: Mutational analyses of the AU-rich translation enhancer. A) A series of manY 
translational fusions containing wild-type or mutant enhancer sequences were assayed 
for β-Galactosidase activity. The top sequence (WT) is the wild-type sequence for the 
 
Fig. 4.4 (cont.) 
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Fig. 4.4 (cont.) 
manX-manY intergenic region. The SD is indicated in blue and start codon in bold black 
letters. The sequences involved in base pairing with SgrS are indicated by the line under 
the sequences. Red letters in mutant sequences indicate positions of substitutions. B) β-
Galactosidase assays of cultures containing indicated carrying the indicated fusions. 
Cells were grown for 2 hr until reaching the mid-log phase and β-galactosidase assays 
were performed. Error bars represent standard deviation from three biological replicates. 
P values (unpaired t test) are shown as: *, P < 0.05; **, P < 0.005; ***, P < 0.0005;****, P 
< 0.0001; NS, not significant. C) Indicated reporter fusions harbored in the degradosome 
mutant strain (rne131::kan) and assayed for β-Galactosidase activity as described in part 
B. D) manY'-'lacZ reporter fusions containing different combinations of SD and enhancer 
sequences were constructed and assayed for β-Galactosidase activity as described in 
part B. Symbols and corresponding sequences are defined in the insets below the 
graph. Fusions are labeled 1 through 10 and discussed in text accordingly. Error bars 
represent standard deviation from three biological replicates.  
 
A number of studies have described AU-rich enhancer sequences located 
upstream of the start codon and SD, where r-protein S1 binds and enhances efficiency 
of translation initiation [15, 31, 62, 78, 137]. We hypothesized that the putative enhancer 
might similarly interact with S1 to promote translation of manY. If this were true, then the 
enhancer activity of this upstream sequence should be independent of SD-anti-SD 
interactions, and the enhancer should promote translation regardless of the strength of 
the SD. To test this possibility, we tested reporter constructs with various combinations 
of enhancer and SD sequences (Fig. 4.4C). As observed in the previous experiment, 
mutation of U residues to G residues (mut3(G)) strongly reduced the activity of the 
reporter fusion with the native manY SD (Fig.  4.4C, compare activity of reporters 1 and 
2). A construct containing the native manY SD and the reverse complement of the 
enhancer region – now A-rich rather than U-rich – had high levels of translation (Fig. 
4.4C, reporter 3), comparable to the wild-type reporter. This result suggests that the 
translation-enhancing effect of this region is not strictly sequence-dependent, but that 
AU-rich sequences in general are stimulatory. This is consistent with the known 
sequence preferences of r-protein S1.  
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We next tested whether the enhancer could stimulate translation from a weaker 
SD. The native manY SD (5'-AGGAG-3') was swapped for the slightly weaker lacZ SD 
(5'-AGGA-3'), leaving the rest of the sequence in the reporter the same. As expected, 
the activity of this reporter was reduced compared to the reporter with the stronger manY 
SD (Fig. 4.4C, compare activity of reporter 1 and reporter 4). The mut3(G) enhancer 
sequence strongly reduced activity (Fig.  4.4C, reporter 5), while the mut5(A) enhancer 
sequence restored the activity (Fig. 4.4C, reporter 6) of the constructs with the lacZ SD. 
The same patterns were seen for two additional SD variants (Fig. 4.4C, reporters 7, 8, 9 
and 10). Regardless of the SD sequence, the wild-type U-rich enhancer promoted higher 
levels of translation, and mutation of U residues to Gs dramatically reduced the 
translation activity. These results suggest that the enhancer functions independent of the 
SD to promote translation. 
 
4.2.4 Ribosome protection of the non-contiguous RBS and translation enhancer 
The analyses presented so far suggest that an upstream enhancer sequence 
plays a positive role in manY translation. We hypothesized the enhancer interacts with 
the initiating ribosome, specifically r-protein S1, and that this interaction increases 
translation initiation. Studies of thrS mRNA, encoding threonyl-tRNA synthetase, showed 
that the 5' UTR of thrS contains a bipartite ribosome binding site where an upstream AU-
rich element interacts with r-protein S1 ([31, 113], Fig.  5A). The AU-rich S1 binding site 
acts as a translational enhancer for thrS mRNA [15, 31, 78, 137]. We used this mRNA 
as a comparison and positive control in the next experiments to further examine the role 
of S1 in regulation of manY translation. We made thrS translational fusions with the wild-
type sequence and mutants where U residues were changed to either Gs or As (Fig. 
5A). β-galactosidase assays showed the same pattern we observed for the manY 
fusions. The wild-type thrS fusion (Fig. 5B, “WT-thrS”) had a high level of activity, which 
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was strongly reduced in the mutant fusion with G residues (Fig. 5B, “G-thrS”) and 
restored in the mutant fusion with A residues (Fig. 5B, “A-thrS”). Footprinting reactions 
performed using RNase T1 (enzymatic) and lead acetate (chemical) probing with end-
labeled mRNA and purified E. coli ribosomes showed the expected bipartite RBS for 
thrS mRNA, with protection around the SD and at the upstream AU-rich enhancer (Fig. 
5C). We then performed footprinting reactions with end-labeled manY mRNA and 
purified ribosomes. In the absence of ribosomes, the pattern of cleavage by lead acetate 
suggested that the sequences around the manY SD and start codon are not very 
accessible and may be sequestered in a secondary structure. This is consistent with 
other examples of S1-dependent translation of mRNAs with highly structured translation 
initiation regions [14, 114]. In the presence of ribosomes, we observed a bipartite 
footprint, similar to the thrS footprint, with protection of the SD and start codon as well as 
protection of the upstream region containing the U-rich enhancer (Fig. 5D). These 
results are consistent with our hypothesis that the manY leader contains an enhancer 
































Fig.  4.5 (cont.) 
 
 
Fig. 4.5: Like known r-protein S1 target thrS, the manY leader contains a bipartite RBS. 
A) Graphical representation of thrS mRNA, including the bipartite RBS. The AU-rich 
region upstream of the SD is known to encompass a binding site for r-protein S1. 
Substitution mutations in the S1 binding site are indicated above in red nucleotides – “G-
thrS” and “A-thrS.” B) thrS'-'lacZ translational fusions were constructed. “WT-thrS” 
indicates the wild-type fusion, “G-thrS” and “A-thrS” are the mutant fusions with 
sequences as indicated in part A. Error bars represent standard deviation from three 
biological replicates. P values (unpaired t test) are shown as: *, P < 0.05; **, P < 0.005; 
***, P < 0.0005;****, P < 0.0001; NS, not significant. C) Ribosome footprint analysis of 
thrS mRNA. In vitro transcribed mRNA was end-labeled with 32P and incubated with and 
without E. coli ribosomes. Lanes are labeled as described in Fig.  2A legend. Positions 
of the start codon and SD are indicated on the left. Ribosome protected nucleotides are 
indicated on the right. D) The manY UTR and early coding region sequences are shown. 
The sequences comprising the SgrS binding site and enhancer are indicated with a line 
above the sequence. The SD and start codon are indicated in blue and red print, 
respectively. The regions protected by the ribosome are indicated with a green line 
below the sequences. The ribosome footprint is labeled as in part C.  
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4.2.5 Ribosomal protein S1 binds to the manY 5' UTR 
A large body of literature has characterized S1 RNA-binding activity [66, 133, 
136, 163]. In gram-negative bacteria, S1 orthologs are composed of six S1 motifs that 
are structurally similar (Fig. 4.6A), but diverge in amino acid sequence [117, 133]. A 
cryo-EM based approach found that the first two motifs of S1 at the N-terminus interact 
with the r-protein S2 and function as a platform for ribosome binding [74]. Using proteins 
with mutations in the S1 motifs, the Marzi group determined that the first three N-
terminal domains are crucial for S1 binding to rpsO mRNA [31]. Several residues of the 
third motif (Y205, F208, H219, and R254) were found to be crucial for interaction with Qβ 
RNA [138]. We aligned S1 proteins from 11 organisms belonging to the Proteobacteria 
and found that three out of these four residues important for RNA binding (Y205, F208, 
H219) were highly conserved (Fig. 4.6B). Alignment of S1 motifs from seven other 
diverse E. coli RNA binding proteins revealed that residues F208 and H219 were still 
fairly well conserved (Fig. 4.6C). These results led us to test whether mutation of 
conserved residues would impact S1 RNA binding activity. To address this question, we 
performed EMSAs with purified wild-type S1 and mutant S1 (mS1, Y205A, F208A, 
H219A) proteins and in vitro transcribed thrS and manY RNAs. Wild-type S1 bound to 
thrS mRNA with a KD of 3.1 nM, while mS1 had a higher KD of 16 nM (Fig. 4.6D). This 
result is consistent with the idea that mS1 is slightly defective for binding a known target. 
The interaction between wild-type S1 and manY mRNA was weaker than for thrS, with a 
KD of 81 nM. As for thrS, the interaction between mS1 and manY RNA was diminished 
(KD = 590 nM, Fig. 4.6E). Though higher than for thrS mRNA, these dissociation 
constants for manY mRNA are in a similar range to those reported previously for other 
S1 targets [107]. Altogether, the data suggest that the third S1 motif is important for 




Fig. 4.6: Characterization of wild-type and mutant S1 (mS1) protein binding to thrS and 
manY mRNAs. A) A structure of S1 (showing six S1 motifs, the N-terminal motif is on the 
right) predicted using I-TASSER homology modeling algorithm based on the deposited 
cryo-EM structure [8]. S1 motif 3 is indicated with a dotted circle. B) A global alignment 
of S1 motif 3 from diverse bacterial species. The alignment was calculated using the 
Clustal Omega algorithm [75] and represented using the ESPript 3 web tool [112]. α-
helices are displayed as squiggles. β-strands are marked with arrows, strict β-turns with 
the letters TT. The ղ symbol was used for 310-helices.  C) A global alignment of S1 motif 
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Fig. 4.6 (cont.) 
3 with amino acid sequences of S1 motifs from other E. coli RNA binding proteins. D-E) 
In vitro transcribed thrS and manY mRNAs were labeled at the 5'-end with P32 and mixed 
with WT S1 or mS1 in a binding buffer for EMSAs. Band intensities were measured for 
three replicates to determine the dissociation constants. 
 
 
Fig. 4.7: S1 unfolds the secondary structures in the manY UTR.  The manY transcript 
was preincubated with S1 or mS1 before chemical modification. DEPC modified in vitro 
transcribed manY transcripts were used as a template for primer extension with a 
reverse transcriptase in the absence or presence of the protein (S1 and mS1), and 
resolved in a polyacrylamide-urea gel. Sanger ladders (T, G, C, and A) were generated 
with dideoxy-sequencing. The enhancer region, the SD, and the start codon are 




To further study the interaction of r-protein S1 and manY mRNA, we performed 
additional footprinting reactions using diethyl pyrocarbonate (DEPC), which primarily 
modifies exposed adenine residues [32]. After treatment with DEPC, a reverse 
transcription reaction using a labeled primer is performed. Bands represent positions 
that were DEPC-modified, causing reverse transcriptase to stop. In the absence of S1 
protein, there was very little modification of A residues around the SD and start codon 
(Fig. 4.7, lane 2), again suggesting that the manY mRNA translation initiation region 
might be sequestered in a secondary structure. In the presence of wild-type S1 protein, 
there was substantially more modification, particularly in the region between the 
enhancer and the SD. This suggests that S1 binding to this region might remodel the 
secondary structure to make it more accessible for formation of the translation initiation 
complex. In the presence of mS1, we also saw new modifications signifying structural 
rearrangements, but these were distinct from the changes seen in the presence of wild-
type S1 (Fig. 4.7). This result is consistent with the EMSA (Fig. 4.6E) and suggests that 
mS1 binds differently (and more weakly) to the manY mRNA. 
 
4.2.6 Evidence of SgrS competition with S1 for control of manY translation  
We hypothesized that SgrS represses manY translation by competing with r-
protein S1 for binding at the enhancer sequence. To test this hypothesis in vivo, we 
constructed plasmids for ectopic expression of S1 and mS1, reasoning that a brief pulse 
of expression could alter the competition between endogenous SgrS and S1 protein. 
Previous work demonstrated that S1 stimulates translation of target genes in a narrow 
range of concentrations – at higher concentrations, S1 represses target translation [14, 
27]. Since manY and thrS have different affinities for S1, we reasoned that S1-
dependent stimulation of translation would require different levels of induction in vivo. 
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Thus, we made two different types of S1 expression constructs – one with a strong SD 
sequence, and one with a weak SD sequence. We transformed plasmids with S1 or mS1 
into strains harboring thrS'-'lacZ (positive control), sodB'-'lacZ (negative control), and 
manY'-'lacZ, and performed β-galactosidase assays after a brief induction. Since thrS 
has a higher affinity for S1, we used expression constructs with the weak SD. In the 
thrS'-'lacZ strain, ectopic production of wild-type S1 resulted in a very slight, but not 
statistically significant increase in β-galactosidase activity. Production of mS1 had a 
more pronounced effect – decreasing the activity by 16% (Fig. 4.8A). This result is 
consistent with the idea that the ectopically produced mS1 protein interferes with 
endogenous S1 activity and inhibits S1-mediated translational activation of a known 
target. In the strain with negative control sodB'-'lacZ, we used S1 and mS1 constructs 
with the strong SD sequence. There was no difference in β-galactosidase activity 
between control and S1- or mS1-producing strains (Fig. 4.8B).  
In the manY'-'lacZ strain, we used the S1 and mS1 constructs with the strong SD 
sequence. We also performed the experiments in the absence and presence of α-methyl 
glucoside, to induce production of SgrS [147]. In the absence of SgrS, we saw the same 
S1-dependent patterns of activity as for thrS. Production of wild-type S1 slightly 
increased the activity of manY'-'lacZ and production of mS1 had an inhibitory effect (Fig.  
4.8C, compare the black bars). As predicted if SgrS and r-protein S1 compete for 
binding to manY mRNA, the efficiency of SgrS-dependent repression varied depending 
on S1 production. In the strain with the vector control, SgrS induction caused a 26% 
reduction in β-galactosidase activity (Fig. 4.8C). (Note, this is a more modest repression 
ratio than seen in other experiments because we used a much shorter time for SgrS 
induction.) In the strain producing wild-type S1, the SgrS-dependent reduction in activity 
was only 16%. This suggests that wild-type S1 overproduction can modestly protect 
manY from SgrS-dependent translational repression. Most strikingly, production of mS1 
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left manY more susceptible to SgrS-dependent repression, with a repression value of 
49% (Fig. 4.8C). These data are all consistent with the model that r-protein S1 
stimulates manY translation, and that SgrS binding inhibits translation by interfering with 
S1-dependent activation.  
 
Fig.  4.8: Short-term ectopic production of S1 or mS1 modulates the efficiency of SgrS-
dependent translational regulation of manY. Low copy plasmids carrying rpsA encoding 
wild-type or mutant r-protein S1 under the control of an IPTG-inducible promoter were 
transformed into strains with thrS'-'lacZ (A), sodB'-'lacZ (B) or manY'-'lacZ (C) fusions 
(reporter fusions were under the control of arabinose-inducible PBAD promoter). Cultures 
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Fig. 4.8 (cont.) 
were grown at 37°C to OD600~0.4 and the reporter fusion was induced with L-arabinose. 
Cells were grown for another 20 minutes before IPTG (to induce S1 or mS1) was added. 
Cultures were grown for an additional 10 min before β-galactosidase assays were 
performed.  For manY'-'lacZ (C) fusions, SgrS and S1 (or mS1) was induced 
instantaneously. Error bars represent standard deviation from three biological replicates. 
P values (unpaired t test) are shown as: *, P < 0.05; **, P < 0.005; ***, P < 0.0005;****, P 






Fig. 4.9: Model of SgrS-mediated enhancer silencing. Our results suggest that the manY 
translation initiation region contains structural elements that are remodeled in part by r-
protein S1 binding to a translational enhancer upstream of the manY SD to promote high 
levels of translation in the absence of the sRNA SgrS. Under glucose-phosphate stress 
conditions, when SgrS is produced, it base pairs with sequences in the enhancer, 
preventing formation of the translation initiation complex. SgrS could inhibit translation 
by sequestering the enhancer and preventing binding of r-protein S1 or by altering a 
crucial the secondary structure that interacts with ribosome-bound S1. 
 
 In this chapter, we show that the E. coli sRNA SgrS, in collaboration with the 
RNA chaperone Hfq, represses manY translation by base-pairing with sequences 
comprising a translational enhancer. The enhancer stimulates manY translation in vitro, 
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suggesting that the effect is mediated by ribosomes and not by other cellular factors. 
The AU-rich enhancer increases translation regardless of the strength of the SD 
sequence. The elements within the manY leader region resemble other so-called 
bipartite RBSs where ribosomes interact with both the SD and start codon region as well 
as a non-contiguous upstream region. Our data implicate r-protein S1 as an important 
mediator of manY translation initiation via interactions with the AU-rich enhancer 
sequence. Our data are consistent with a model where SgrS competes with S1 for 
binding to the enhancer sequences, thereby reducing S1-dependent translation and 
resulting in the observed SgrS-dependent repression of manY (Fig. 9).  
The RNA chaperone Hfq is essential for manY translation repression by SgrS in 
vivo (Fig.  1C). Hfq is a pleiotropic global regulator of gene expression, owing to its 
dynamic and complex interaction patterns with many cellular RNAs }[81, 149, 160]. The 
involvement of Hfq in sRNA-mediated translational repression has been attributed to its 
ability to remodel RNA secondary structures and overcome energetic barriers presented 
by one or both RNA partners, and to enhance local concentrations of potential binding 
partners to increase the rates of association [118]. A recent report illustrated an example 
of Hfq-dependent structural remodeling of dgcM mRNA to allow duplex formation with 
OmrA or OmrB sRNAs, which results in translational repression of dcgM [50]. Similar 
mechanisms have been found for other sRNA-mRNA pairs that require Hfq-dependent 
structure remodeling [22, 161]. In this study, Hfq was required in vivo for SgrS-
dependent regulation of manY (Fig.  1C). In vitro, the presence of Hfq promoted SgrS-
dependent protection of manY mRNA (Fig. 2A, B), and adding Hfq to in vitro annealing 
reactions resulted in a 10-fold reduction in SgrS-manY KD (Fig. 2C, D). However, we did 
not observe Hfq-mediated structural changes in our footprint experiments (Fig.  2A, B). 
We hypothesize that SgrS sequesters the enhancer from ribosome-associated S1 
protein (Fig. 9). This model could explain why Hfq is essential for SgrS-mediated 
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silencing of the enhancer in vivo. S1 forms a complex with manY with a KD of 80.5 nM 
(Fig. 6E) while SgrS forms a complex at a higher stoichiometry (KD of 7.1 µM, Fig. 2C). 
In the presence of Hfq, the SgrS-manY complex has a submicromolar dissociation 
constant (KD of 0.77 µM, Fig. 2E), which could allow SgrS to effectively compete with S1 
for binding to the same site on manY mRNA. 
The manY mRNA leader possesses a bipartite RBS. The RBS of a gene often 
extends beyond the start codon and the SD [64, 124, 127] with a non-contiguous 
architecture where additional sequences in the 5' leader establish interactions with 
ribosomal proteins and modulate translation initiation complex formation [26, 44, 65, 97, 
144]. The threonyl-tRNA synthetase (thrS) mRNA contains a bipartite RBS, with an 
upstream single-stranded U-rich enhancer that is separated from the SD region by a 
stem-loop structure. For thrS mRNA, the enhancer is recognized by r-protein S1 [116]. 
This is just one example of an S1 binding site, and there are many other varieties [14, 
31, 114, 116], making it difficult to identify S1 binding sites based on sequence or 
structural characteristics. The manY enhancer is centered at ~25 nt upstream of the SD 
and we see a bipartite pattern of ribosome-dependent protection (Fig. 5D) similar to the 
pattern for known S1 target thrS mRNA (Fig. 5C). In the absence of ribosomes, the 
manY SD and start codon region is not accessible to cleavage by lead acetate (Fig.  
5D), suggesting it is structured. This is common for mRNAs whose translation is 
activated by r-protein S1, as S1 binding upstream can promote unfolding of secondary 
structure to allow formation of ribosome preinitiation complexes [7, 61, 107]. Our DEPC 
modification and footprinting experiments also showed that the SD and start codon 
region of manY mRNA is rather inaccessible to modification, and that addition of S1 
slightly enhances accessibility of these sequences (Fig. 7). Consistent with our results, 
other studies have demonstrated S1-mediated unfolding of secondary structures with 
free S1 proteins [7, 107]. In an elegant study, the Marzi group demonstrated that 
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ribosome-bound S1 could unfold rpsO mRNA and expose the SD region more efficiently 
than free S1 protein [31]. Another recent study showed how ribosome-associated S1 
prevents secondary structure formation and exposes an otherwise inaccessible SD of 
the tisB mRNA [114]. With assistance from neighboring ribosomal components, S1 might 
play a more prominent role in remodeling the secondary structure of manY mRNA in its 
natural ribosome context. Nevertheless, our data are consistent with a model where 
manY translation is enhanced by r-protein S1 binding to a region upstream of the SD in 
the absence of SgrS (Fig. 9).  
Both technical challenges and opportunities continue to arise as we discover 
more and more examples of sRNA-mediated translational regulation from a distance, 
i.e., outside the boundaries where canonical steric occlusion of the SD and start codon 
are possible. There are many mRNAs with very long and highly structured 5' leaders, 
and doubtless an array of new regulatory mechanisms controlling mRNA translation and 
stability are yet to be discovered. Our study and the numerous recent global analyses of 
RNA-RNA interactomes [3, 28, 123] suggest that there are dozens of targets for most 
sRNAs, and we must expand the search window beyond the SD and start codon region 
when looking for sRNA target binding sites. Mechanistic characterization of 5' UTR-
targeting sRNAs could reveal new functional elements involved in translation initiation 














In bacteria, we have yet to uncover the mechanistic details of regulation carried 
out by the vast majority of sRNAs, but of those for which mechanisms have been 
established, sRNAs are typically the primary effectors of regulation. This raises some 
intriguing questions. Is the “canonical” mechanism of sRNA-mediated regulation with 
sRNA as primary regulator truly the most common, or have computational and 
experimental approaches used to study sRNAs been biased toward discovery of these 
mechanisms because they were the first type described? Regardless of the prevalence 
of each of these two different mechanisms, what features distinguish them and make 
one or the other more favorable for regulation of a given mRNA target?  
One advantage of sRNA-mediated regulation that involves base pairing 
interactions outside the TIR could be that it provides a larger and more diverse 
sequence space to evolve new regulatory interactions. We have found that regulation of 
ptsG, the primary glucose transporter, by SgrS is conserved among E. coli relatives 
where SgrS orthologs were found [53, 151]. The SgrS-ptsG mRNA interaction involves 
pairing between the most highly conserved seed region of SgrS and the ptsG RBS, a 
region where the sequence is highly conserved for ribosome binding. In contrast, SgrS-
dependent regulation of manX involves a less well-conserved portion of SgrS (adjacent 
to the conserved seed) and the coding sequence of manX, and this interaction is not 
entirely conserved among enteric species. For instance, E. carotovora SgrS and Y. 
pestis SgrS do not regulate their cognate manX orthologs [110] because the SgrS 
sequences that pair with manX mRNA are not conserved in these organisms. Analyses 
by Peer and Margalit [102] indicate that the SgrS-ptsG mRNA interaction evolved first, 
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with the binding sites on both mRNA and sRNA co-appearing in evolutionary time [102]. 
Their data suggest that SgrS-manX mRNA interaction evolved much later. So, SgrS first 
established a regulatory interaction with ptsG in an ancestral organism of the order 
Enterobacteriales, which established this sRNA regulator in the genome and allowed 
evolution of interactions with additional targets. Other recent work on sRNA evolution 
suggests similar target acquisition mechanisms where sRNAs establish one target and 
gradually establish other interactions with the concurrent evolution of Hfq [102, 111]. 
Perhaps flexibility in regulatory mechanisms, e.g., where the sRNA can act as either a 
primary or accessory regulator along with Hfq, facilitates rapid evolution of additional 
sRNA-target interactions.  
A long-held notion about sRNA-mediated gene regulation in eukaryotes is that 
the primary role of sRNAs is target recognition, while the associated protein partners 
perform the primary regulatory function of gene silencing or translational repression. In 
bacteria, the prevailing model has been the oppositethat the sRNA is the primary 
regulator and associated proteins play secondary roles in promoting RNA stability or 
making the regulation irreversible (in the case of mechanisms involving mRNA 
degradation). Our findings, along with one other recent report on a similar non-canonical 
mechanism of regulation in bacteria [28] suggest that bacteria can utilize a broader 
range of sRNA-mediated regulatory strategies than previously suspected. So, while 
there are considerable differences among the domains in terms of the mechanisms of 
translation initiation, sites of sRNA binding, and the nature of the ribonucleoprotein 
complexes carrying out regulation, sRNA-mediated regulation of mRNA targets appears 
to be a common mode of regulation in all three domains of life. 
The data presented in Chapter 4 proposes an intriguing mechanism where the 
sRNA sequesters a protein binding site. Similar to the transcriptional UP element, 
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translation enhancers could also be exploited by cells to modulate translation. 
Translation enhancers can potentially influence either ribosome binding or ribosome 
liberation from the SD element. The position requirement of enhancer sequence for the 
functioning of the enhancer suggests that it ensures an anchor point and subsequently 
facilitates TIC formation.  A recent study by Takahashi and colleagues reported that 
translation has no effect on the kon, rather it increases the koff between the ribosome and 
the SD sequence increasing translation efficiency [137]. Here, the enhancer/S1 
interaction works against the SD/anti-SD interaction and shift the equilibrium towards the 
elongation state, which is a striking example of negative allosteric modulation. Some of 
the data presented in this report tentatively suggests that similar mechanism could be in 
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